Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
IPSC.mesodermal_primed: Meta traits — page 2
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,329 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1,001–2,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1001 | Anxiety | PSYCH000022 | 3.26 | Psychiatric | Neural / glial | 45 | 4 | 8 | 19 | |
| 1002 | NRAC levels | PROLV001431 | 3.25 | Protein levels | Myeloid | 0 | 2 | 5 | 13 | |
| 1003 | B4GALT1/SMOC2 ratio | PRORT000189 | 3.24 | Protein ratios | Myeloid | 7 | 2 | 6 | 18 | |
| 1004 | EHBP1 levels | PROLV000689 | 3.24 | Protein levels | Stromal / connective | 18 | 3 | 5 | 18 | |
| 1005 | MAP4K5/TBCB ratio | PRORT001491 | 3.23 | Protein ratios | Neural / glial | 5 | 4 | 8 | 23 | |
| 1006 | Fruit preference | DTSUP000012 | 3.22 | Diet and Supplement | Neural / glial | 59 | 4 | 8 | 19 | |
| 1007 | PFKM levels | PROLV001541 | 3.22 | Protein levels | Lymphocyte | 0 | 3 | 15 | 30 | |
| 1008 | Social relationships | SOCIO000021 | 3.22 | Socioeconomic | Neural / glial | 17 | 5 | 9 | 17 | |
| 1009 | Corns and callosities | DERMA000023 | 3.21 | Dermatologic | Cutaneous epithelium | 3 | 0 | 3 | 3 | |
| 1010 | Brain susceptibility | NIMAG000008 | 3.21 | Neuroimaging | Myeloid | 139 | 3 | 7 | 12 | |
| 1011 | ADAM23 levels | PROLV000028 | 3.21 | Protein levels | Granulosa cell | 35 | 1 | 4 | 4 | |
| 1012 | CORO1A levels | PROLV000499 | 3.20 | Protein levels | Platelet | 2 | 2 | 6 | 14 | |
| 1013 | Infant mortality rate | MISCL000003 | 3.19 | Miscellaneous | Myeloid | 1 | 3 | 10 | 20 | |
| 1014 | CD163/MSR1 ratio | PRORT000384 | 3.19 | Protein ratios | Myeloid | 62 | 3 | 10 | 14 | |
| 1015 | ITGB1BP2/MED18 ratio | PRORT001384 | 3.18 | Protein ratios | Muscle / cardiac | 0 | 4 | 7 | 17 | |
| 1016 | Medication, antihypertensive | VASCU000031 | 3.18 | Vascular | Vascular | 332 | 2 | 4 | 9 | |
| 1017 | Other ear disorder | AUDIO000004 | 3.17 | Auditory | Epithelial | 6 | 0 | 7 | 9 | |
| 1018 | Severe mental illness | PSYCH000017 | 3.15 | Psychiatric | Neural / glial | 0 | 4 | 8 | 10 | |
| 1019 | Hypercholesterolaemia | METBL000021 | 3.15 | Metabolic | Hepatocyte | 462 | 1 | 7 | 8 | |
| 1020 | Skin appendage disorder | DERMA000035 | 3.15 | Dermatologic | Myeloid | 6 | 2 | 7 | 9 | |
| 1021 | GPNMB levels | PROLV000927 | 3.14 | Protein levels | Hepatocyte | 49 | 5 | 9 | 24 | |
| 1022 | Ganglion cyst | MSKEL000065 | 3.14 | Musculoskeletal | Stromal / connective | 0 | 1 | 3 | 12 | |
| 1023 | Phosphatidylcholines | LIPID000058 | 3.14 | Lipids | Hepatocyte | 408 | 1 | 3 | 17 | |
| 1024 | LTBP2 levels | PROLV001242 | 3.13 | Protein levels | Myeloid | 145 | 4 | 14 | 23 | |
| 1025 | Implant | MISCL000025 | 3.13 | Miscellaneous | Stromal / connective | 0 | 0 | 0 | 0 | |
| 1026 | Hereditary haemolytic anaemia | HEMAT000010 | 3.12 | Hematologic | B / plasma cell | 0 | 1 | 7 | 5 | |
| 1027 | Glucose levels | METBL000037 | 3.12 | Metabolic | Hepatocyte | 1,438 | 1 | 6 | 8 | |
| 1028 | Depression | PSYCH000024 | 3.12 | Psychiatric | Neural / glial | 57 | 3 | 8 | 12 | |
| 1029 | Gut microbial abundance, Bifidobacterium | GASTR000019 | 3.12 | Gastrointestinal | B / plasma cell | 0 | 3 | 6 | 20 | |
| 1030 | Brain MRI signal intensity | NIMAG000003 | 3.10 | Neuroimaging | Neural / glial | 143 | 4 | 7 | 15 | |
| 1031 | CDH2/CDHR2 ratio | PRORT000552 | 3.10 | Protein ratios | Hepatocyte | 39 | 1 | 6 | 11 | |
| 1032 | Haemoglobin | HEMAT000007 | 3.09 | Hematologic | Hepatocyte | 2,197 | 1 | 4 | 10 | |
| 1033 | ITGB1/TFPI ratio | PRORT001381 | 3.07 | Protein ratios | Hepatocyte | 52 | 1 | 14 | 13 | |
| 1034 | Maximal oxygen uptake | CARDI000026 | 3.07 | Cardiac | B / plasma cell | 1 | 4 | 12 | 22 | |
| 1035 | FLT3 levels | PROLV000816 | 3.07 | Protein levels | Myeloid | 50 | 4 | 11 | 22 | |
| 1036 | DSG4 levels | PROLV000657 | 3.06 | Protein levels | Cutaneous epithelium | 24 | 1 | 7 | 10 | |
| 1037 | SLC5A8 levels | PROLV001884 | 3.06 | Protein levels | Hepatocyte | 11 | 3 | 7 | 10 | |
| 1038 | Ischaemic heart disease | CARDI000041 | 3.06 | Cardiac | Vascular | 595 | 3 | 10 | 19 | |
| 1039 | Urinary tract infection | IMMUN000074 | 3.06 | Immunologic | Neural / glial | 1 | 1 | 3 | 7 | |
| 1040 | YES1 levels | PROLV002205 | 3.06 | Protein levels | Hepatocyte | 28 | 2 | 6 | 13 | |
| 1041 | MDK levels | PROLV001290 | 3.05 | Protein levels | Myeloid | 102 | 2 | 7 | 16 | |
| 1042 | Cardiovascular disease | CARDI000035 | 3.05 | Cardiac | Vascular | 145 | 3 | 8 | 11 | |
| 1043 | Pancreatitis | HPBIL000027 | 3.05 | Hepatopancreatobiliary | Hepatocyte | 57 | 0 | 1 | 7 | |
| 1044 | Hyperparathyroidism | ENDOC000004 | 3.05 | Endocrine | Hepatocyte | 0 | 3 | 8 | 17 | |
| 1045 | ULBP2 levels | PROLV002139 | 3.04 | Protein levels | Granulosa cell | 11 | 0 | 4 | 7 | |
| 1046 | MIA/NBL1 ratio | PRORT001532 | 3.04 | Protein ratios | Stromal / connective | 22 | 3 | 7 | 17 | |
| 1047 | SPINK6 levels | PROLV001931 | 3.04 | Protein levels | Cutaneous epithelium | 0 | 1 | 13 | 10 | |
| 1048 | Phospholipids, LDL | LIPID000050 | 3.03 | Lipids | Hepatocyte | 1,023 | 1 | 6 | 12 | |
| 1049 | CXCL6/DFFA ratio | PRORT000834 | 3.03 | Protein ratios | Hepatocyte | 2 | 2 | 9 | 18 | |
| 1050 | ISLR2 levels | PROLV001101 | 3.02 | Protein levels | Granulosa cell | 65 | 4 | 11 | 16 | |
| 1051 | PI16 levels | PROLV001553 | 3.02 | Protein levels | Myeloid | 144 | 1 | 6 | 16 | |
| 1052 | Carbohydrate metabolites | METAB000035 | 3.01 | Metabolites | Hepatocyte | 7 | 2 | 13 | 22 | |
| 1053 | DAPP1/ITGB1BP2 ratio | PRORT000854 | 2.99 | Protein ratios | Myeloid | 21 | 5 | 19 | 31 | |
| 1054 | Nerve root and plexus disorder | NEURO000029 | 2.98 | Neurologic | Myeloid | 0 | 2 | 8 | 12 | |
| 1055 | MITD1/RHOC ratio | PRORT001536 | 2.98 | Protein ratios | Myeloid | 13 | 3 | 8 | 8 | |
| 1056 | Phospholipids, IDL | LIPID000049 | 2.98 | Lipids | Hepatocyte | 536 | 2 | 8 | 13 | |
| 1057 | Liver disorder | HPBIL000011 | 2.97 | Hepatopancreatobiliary | Hepatocyte | 78 | 1 | 3 | 11 | |
| 1058 | Chest pain | CARDI000052 | 2.97 | Cardiac | Neural / glial | 19 | 4 | 16 | 46 | |
| 1059 | BCAM/NOTCH1 ratio | PRORT000211 | 2.97 | Protein ratios | Hepatocyte | 27 | 2 | 10 | 10 | |
| 1060 | CD40LG/EREG ratio | PRORT000450 | 2.96 | Protein ratios | Myeloid | 44 | 2 | 7 | 10 | |
| 1061 | BCAM/CLEC14A ratio | PRORT000207 | 2.96 | Protein ratios | Vascular | 26 | 1 | 12 | 8 | |
| 1062 | IFNGR1/THBD ratio | PRORT001332 | 2.95 | Protein ratios | Vascular | 22 | 3 | 9 | 14 | |
| 1063 | DDR1/PVR ratio | PRORT000879 | 2.95 | Protein ratios | Hepatocyte | 15 | 1 | 7 | 13 | |
| 1064 | AMY2B levels | PROLV000091 | 2.94 | Protein levels | Hepatocyte | 58 | 1 | 6 | 9 | |
| 1065 | ASAH2 levels | PROLV000150 | 2.94 | Protein levels | Myeloid | 115 | 3 | 7 | 17 | |
| 1066 | Osteomyelitis | IMMUN000068 | 2.93 | Immunologic | Stromal / connective | 19 | 2 | 4 | 5 | |
| 1067 | Immune cell marker, pDC | HEMAT000028 | 2.92 | Hematologic | Myeloid | 0 | 3 | 12 | 14 | |
| 1068 | Influenza | IMMUN000065 | 2.92 | Immunologic | B / plasma cell | 21 | 3 | 6 | 11 | |
| 1069 | Hypertension | VASCU000027 | 2.92 | Vascular | Vascular | 668 | 3 | 5 | 11 | |
| 1070 | GRN levels | PROLV000933 | 2.91 | Protein levels | Myeloid | 36 | 1 | 4 | 9 | |
| 1071 | Tryptophan metabolites | METAB000015 | 2.91 | Metabolites | Hepatocyte | 39 | 0 | 2 | 11 | |
| 1072 | LBR/MAD1L1 ratio | PRORT001438 | 2.91 | Protein ratios | Myeloid | 0 | 3 | 10 | 24 | |
| 1073 | OSMR levels | PROLV001476 | 2.91 | Protein levels | Lymphocyte | 78 | 3 | 14 | 34 | |
| 1074 | CRELD1 levels | PROLV000518 | 2.91 | Protein levels | Myeloid | 51 | 2 | 8 | 20 | |
| 1075 | Brugada syndrome | CARDI000020 | 2.91 | Cardiac | Muscle / cardiac | 27 | 4 | 6 | 7 | |
| 1076 | LRP11/NECTIN2 ratio | PRORT001460 | 2.90 | Protein ratios | Vascular | 14 | 2 | 10 | 10 | |
| 1077 | Vertigo | AUDIO000021 | 2.89 | Auditory | Neural / glial | 0 | 2 | 3 | 15 | |
| 1078 | Atrioventricular block | CARDI000028 | 2.89 | Cardiac | Muscle / cardiac | 7 | 4 | 6 | 19 | |
| 1079 | CDH17 levels | PROLV000373 | 2.89 | Protein levels | Myeloid | 57 | 1 | 5 | 14 | |
| 1080 | IGFBP1 levels | PROLV001028 | 2.88 | Protein levels | Hepatocyte | 15 | 1 | 7 | 11 | |
| 1081 | Angina pectoris | CARDI000039 | 2.87 | Cardiac | Vascular | 317 | 5 | 9 | 18 | |
| 1082 | FIS1/HSPA1A ratio | PRORT001149 | 2.86 | Protein ratios | Hepatocyte | 34 | 3 | 9 | 20 | |
| 1083 | Breast disorder | BREAS000002 | 2.86 | Breast | Respiratory epithelium | 0 | 0 | 11 | 13 | |
| 1084 | Uterine or vaginal bleeding | REPRO000044 | 2.84 | Reproductive | Stromal / connective | 0 | 5 | 8 | 16 | |
| 1085 | AGRP levels | PROLV000058 | 2.84 | Protein levels | Myeloid | 131 | 2 | 4 | 7 | |
| 1086 | ADGRE2/B4GALT1 ratio | PRORT000027 | 2.83 | Protein ratios | Myeloid | 57 | 3 | 11 | 23 | |
| 1087 | DAPP1 levels | PROLV000594 | 2.83 | Protein levels | Stromal / connective | 37 | 2 | 6 | 13 | |
| 1088 | MAP2K6/TBL1X ratio | PRORT001487 | 2.82 | Protein ratios | Myeloid | 10 | 4 | 12 | 28 | |
| 1089 | RECK levels | PROLV001716 | 2.82 | Protein levels | Myeloid | 64 | 0 | 7 | 7 | |
| 1090 | Benign neoplasm, Colorectal | MALIG000002 | 2.82 | Malignancy | Stromal / connective | 41 | 0 | 4 | 4 | |
| 1091 | SEPTIN3 levels | PROLV001813 | 2.81 | Protein levels | B / plasma cell | 64 | 3 | 5 | 25 | |
| 1092 | Anal and rectal disorder | GASTR000001 | 2.79 | Gastrointestinal | Gastrointestinal epithelium | 1 | 0 | 7 | 4 | |
| 1093 | Lipoprotein particles, VLDL | LIPID000046 | 2.79 | Lipids | Hepatocyte | 1,175 | 2 | 8 | 20 | |
| 1094 | PLSCR3 levels | PROLV001581 | 2.78 | Protein levels | Stromal / connective | 15 | 4 | 7 | 16 | |
| 1095 | Diabetes, type 1 with complication | IMMUN000011 | 2.78 | Immunologic | Neural / glial | 14 | 0 | 2 | 7 | |
| 1096 | DSG2 levels | PROLV000655 | 2.77 | Protein levels | Epithelial | 31 | 0 | 9 | 6 | |
| 1097 | VCAN levels | PROLV002156 | 2.77 | Protein levels | Adipose | 116 | 3 | 8 | 21 | |
| 1098 | MBL2 levels | PROLV001282 | 2.77 | Protein levels | B / plasma cell | 15 | 2 | 7 | 23 | |
| 1099 | AXIN1/MAP2K6 ratio | PRORT000174 | 2.77 | Protein ratios | Granulosa cell | 0 | 3 | 5 | 12 | |
| 1100 | SUGT1/TBL1X ratio | PRORT001822 | 2.76 | Protein ratios | Myeloid | 0 | 4 | 10 | 14 | |
| 1101 | CREG1/NAAA ratio | PRORT000752 | 2.75 | Protein ratios | Granulosa cell | 9 | 3 | 11 | 23 | |
| 1102 | Biventricular shape | CARDI000010 | 2.74 | Cardiac | Muscle / cardiac | 44 | 2 | 4 | 12 | |
| 1103 | HLA-A levels | PROLV000972 | 2.74 | Protein levels | Myeloid | 143 | 3 | 11 | 29 | |
| 1104 | SLITRK6 levels | PROLV001890 | 2.74 | Protein levels | Adipose | 4 | 2 | 11 | 17 | |
| 1105 | Sepsis | IMMUN000071 | 2.73 | Immunologic | Vascular | — | 1 | 6 | 7 | |
| 1106 | SEMA4D/TXNDC5 ratio | PRORT001772 | 2.73 | Protein ratios | Stromal / connective | 0 | 3 | 6 | 14 | |
| 1107 | Total lipids, lipoprotein particles | LIPID000078 | 2.72 | Lipids | Hepatocyte | 314 | 1 | 7 | 15 | |
| 1108 | LRRC59 levels | PROLV001234 | 2.72 | Protein levels | Myeloid | 5 | 3 | 6 | 12 | |
| 1109 | Exophthalmic conditions | OPHTH000018 | 2.72 | Ophthalmic | Adipose | — | 2 | 9 | 12 | |
| 1110 | DMP1 levels | PROLV000628 | 2.72 | Protein levels | Myeloid | 89 | 3 | 8 | 11 | |
| 1111 | CD244/GP1BA ratio | PRORT000409 | 2.72 | Protein ratios | Hematopoietic progenitor | 5 | 2 | 12 | 34 | |
| 1112 | Clonal haematopoiesis | HEMAT000015 | 2.72 | Hematologic | Myeloid | 54 | 2 | 3 | 15 | |
| 1113 | CCL16 levels | PROLV000282 | 2.72 | Protein levels | Hepatocyte | 117 | 2 | 8 | 16 | |
| 1114 | GSTT2B levels | PROLV000943 | 2.72 | Protein levels | Muscle / cardiac | 20 | 2 | 5 | 11 | |
| 1115 | HEXIM1/NUB1 ratio | PRORT001279 | 2.71 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 11 | |
| 1116 | NGRN levels | PROLV001402 | 2.71 | Protein levels | Myeloid | 0 | 3 | 9 | 13 | |
| 1117 | Benign neoplasm, Uterus | MALIG000008 | 2.71 | Malignancy | Lymphocyte | 38 | 0 | 2 | 26 | |
| 1118 | SNX18 levels | PROLV001912 | 2.70 | Protein levels | Hepatocyte | 0 | 1 | 8 | 17 | |
| 1119 | Medication, musculoskeletal | MSKEL000026 | 2.70 | Musculoskeletal | Stromal / connective | 0 | 2 | 5 | 5 | |
| 1120 | Physical decline | AGING000005 | 2.69 | Aging | Muscle / cardiac | 0 | 4 | 15 | 14 | |
| 1121 | Cerebral amyloid angiopathy | NEURO000003 | 2.69 | Neurologic | Vascular | 2 | 0 | 6 | 7 | |
| 1122 | Bundle branch block | CARDI000029 | 2.69 | Cardiac | Muscle / cardiac | 13 | 3 | 6 | 11 | |
| 1123 | Cardiac pacemaker | CARDI000049 | 2.69 | Cardiac | Muscle / cardiac | 22 | 3 | 14 | 22 | |
| 1124 | Metabolon metabolite | METAB000076 | 2.68 | Metabolites | Hepatocyte | 164 | 1 | 2 | 11 | |
| 1125 | CALCOCO1/PFKFB2 ratio | PRORT000301 | 2.68 | Protein ratios | Myeloid | 1 | 5 | 10 | 23 | |
| 1126 | EBAG9/EDAR ratio | PRORT000957 | 2.67 | Protein ratios | Myeloid | 27 | 4 | 12 | 16 | |
| 1127 | FAM3C/NECTIN2 ratio | PRORT001115 | 2.67 | Protein ratios | Vascular | 19 | 1 | 12 | 10 | |
| 1128 | F9 levels | PROLV000750 | 2.67 | Protein levels | Myeloid | 24 | 6 | 12 | 31 | |
| 1129 | LGALS8 levels | PROLV001206 | 2.67 | Protein levels | Vascular | 13 | 3 | 8 | 21 | |
| 1130 | Family history, diabetes | METBL000009 | 2.66 | Metabolic | Hematopoietic progenitor | 0 | 1 | 1 | 5 | |
| 1131 | Prospective memory | PSYCH000009 | 2.66 | Psychiatric | Neural / glial | 18 | 4 | 13 | 19 | |
| 1132 | CDKN2D/ITGB1BP2 ratio | PRORT000578 | 2.66 | Protein ratios | Hematopoietic progenitor | 17 | 5 | 12 | 35 | |
| 1133 | Brain functional connectivity | NIMAG000002 | 2.65 | Neuroimaging | Neural / glial | 0 | 0 | 0 | 0 | |
| 1134 | BCAM levels | PROLV000181 | 2.65 | Protein levels | Hepatocyte | 79 | 2 | 14 | 15 | |
| 1135 | CD69/PPP1R2 ratio | PRORT000496 | 2.65 | Protein ratios | Vascular | 8 | 1 | 12 | 14 | |
| 1136 | Citrulline | METAB000020 | 2.65 | Metabolites | Muscle / cardiac | 0 | 1 | 6 | 5 | |
| 1137 | Gait abnormality | NEURO000014 | 2.64 | Neurologic | Neural / glial | 0 | 4 | 11 | 17 | |
| 1138 | ART3/GPC1 ratio | PRORT000144 | 2.64 | Protein ratios | Muscle / cardiac | 13 | 1 | 5 | 9 | |
| 1139 | Triglycerides/HDL cholesterol | LIPID000041 | 2.64 | Lipids | Hepatocyte | 792 | 3 | 9 | 19 | |
| 1140 | TPI1 levels | PROLV002093 | 2.64 | Protein levels | Neural / glial | 1 | 1 | 13 | 20 | |
| 1141 | HPCAL1/NUDC ratio | PRORT001297 | 2.64 | Protein ratios | Myeloid | 0 | 1 | 11 | 22 | |
| 1142 | TNFRSF11B/TNFSF11 ratio | PRORT001845 | 2.63 | Protein ratios | Hepatocyte | 18 | 1 | 9 | 11 | |
| 1143 | DDR1 levels | PROLV000610 | 2.63 | Protein levels | Melanocyte | 92 | 3 | 14 | 23 | |
| 1144 | OSCAR/TNFRSF14 ratio | PRORT001616 | 2.62 | Protein ratios | Myeloid | 26 | 4 | 9 | 14 | |
| 1145 | CXADR/MME ratio | PRORT000813 | 2.62 | Protein ratios | Epithelial | 21 | 1 | 3 | 6 | |
| 1146 | ARG1 levels | PROLV000134 | 2.62 | Protein levels | Muscle / cardiac | 18 | 3 | 13 | 28 | |
| 1147 | CDKN1A/ENO2 ratio | PRORT000566 | 2.61 | Protein ratios | Hepatocyte | 21 | 3 | 8 | 18 | |
| 1148 | GPR37 levels | PROLV000929 | 2.60 | Protein levels | Hepatocyte | 88 | 2 | 9 | 21 | |
| 1149 | CD244/CD84 ratio | PRORT000405 | 2.60 | Protein ratios | Myeloid | 16 | 1 | 8 | 8 | |
| 1150 | SRC/STAT5B ratio | PRORT001813 | 2.60 | Protein ratios | Hepatocyte | 0 | 3 | 12 | 22 | |
| 1151 | MAVS/MED18 ratio | PRORT001495 | 2.58 | Protein ratios | Lymphocyte | 20 | 6 | 15 | 39 | |
| 1152 | CPXM1/DKK1 ratio | PRORT000732 | 2.58 | Protein ratios | Hematopoietic progenitor | 9 | 3 | 10 | 9 | |
| 1153 | Medication, beta blocker | VASCU000034 | 2.58 | Vascular | Vascular | 48 | 3 | 8 | 16 | |
| 1154 | Diglycerides | LIPID000038 | 2.57 | Lipids | Hepatocyte | 32 | 1 | 5 | 16 | |
| 1155 | Diabetes, type 2 | METBL000034 | 2.57 | Metabolic | Hepatocyte | 723 | 0 | 3 | 5 | |
| 1156 | Frailty, metabolic problems | METBL000011 | 2.56 | Metabolic | Lymphocyte | 3 | 4 | 17 | 37 | |
| 1157 | SDC1 levels | PROLV001796 | 2.56 | Protein levels | Hepatocyte | 98 | 1 | 9 | 9 | |
| 1158 | GAL levels | PROLV000847 | 2.56 | Protein levels | Hepatocyte | 129 | 1 | 11 | 16 | |
| 1159 | MGLL/PDLIM7 ratio | PRORT001528 | 2.56 | Protein ratios | Hepatocyte | 10 | 2 | 8 | 13 | |
| 1160 | Pulmonary fibrosis | RESPI000017 | 2.56 | Respiratory | Lymphocyte | 5 | 2 | 12 | 33 | |
| 1161 | Phenylalanine | METAB000027 | 2.56 | Metabolites | Hepatocyte | 104 | 1 | 4 | 10 | |
| 1162 | IZUMO4 levels | PROLV001123 | 2.56 | Protein levels | Myeloid | 2 | 3 | 10 | 21 | |
| 1163 | CDON levels | PROLV000385 | 2.56 | Protein levels | Granulosa cell | 4 | 5 | 10 | 14 | |
| 1164 | AMBP/ASGR1 ratio | PRORT000084 | 2.55 | Protein ratios | Hepatocyte | 68 | 1 | 6 | 6 | |
| 1165 | Visual impairment | OPHTH000046 | 2.55 | Ophthalmic | Stromal / connective | 28 | 0 | 2 | 7 | |
| 1166 | Lactosylceramides | LIPID000070 | 2.54 | Lipids | Myeloid | 39 | 3 | 9 | 15 | |
| 1167 | Heme malignancy, Lymphoid | MALIG000043 | 2.54 | Malignancy | B / plasma cell | 44 | 3 | 15 | 27 | |
| 1168 | Androgen metabolite | METAB000071 | 2.52 | Metabolites | Hepatocyte | 77 | 1 | 6 | 13 | |
| 1169 | CD40/GLOD4 ratio | PRORT000443 | 2.52 | Protein ratios | Muscle / cardiac | 0 | 1 | 4 | 9 | |
| 1170 | RCC1 levels | PROLV001715 | 2.51 | Protein levels | B / plasma cell | 14 | 2 | 8 | 21 | |
| 1171 | MANF/NCK2 ratio | PRORT001476 | 2.51 | Protein ratios | Myeloid | 13 | 3 | 8 | 15 | |
| 1172 | MFGE8 levels | PROLV001307 | 2.51 | Protein levels | Myeloid | 168 | 3 | 13 | 26 | |
| 1173 | BLVRB/HMBS ratio | PRORT000243 | 2.49 | Protein ratios | Neural / glial | 14 | 5 | 14 | 29 | |
| 1174 | GALNT10/SEMA7A ratio | PRORT001202 | 2.48 | Protein ratios | Lymphocyte | 3 | 2 | 11 | 33 | |
| 1175 | IMPA1/TBCC ratio | PRORT001358 | 2.48 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 13 | |
| 1176 | Sugar alcohols | METAB000037 | 2.48 | Metabolites | Vascular | 0 | 1 | 4 | 12 | |
| 1177 | C7 levels | PROLV000236 | 2.48 | Protein levels | Adipose | 12 | 2 | 11 | 27 | |
| 1178 | Lens replacement | OPHTH000025 | 2.47 | Ophthalmic | Vascular | 12 | 2 | 13 | 17 | |
| 1179 | ATP5IF1/LYN ratio | PRORT000159 | 2.45 | Protein ratios | B / plasma cell | 1 | 3 | 18 | 33 | |
| 1180 | RET levels | PROLV001724 | 2.45 | Protein levels | Stromal / connective | 18 | 5 | 10 | 21 | |
| 1181 | GFER/TRIAP1 ratio | PRORT001206 | 2.45 | Protein ratios | Granulosa cell | 1 | 4 | 6 | 22 | |
| 1182 | CTSZ levels | PROLV000570 | 2.45 | Protein levels | Hepatocyte | 81 | 1 | 7 | 12 | |
| 1183 | Smoking behaviour | PSYCH000046 | 2.45 | Psychiatric | Neural / glial | 201 | 5 | 10 | 23 | |
| 1184 | EDAR/YES1 ratio | PRORT000985 | 2.43 | Protein ratios | Myeloid | 30 | 5 | 12 | 27 | |
| 1185 | HEXIM1 levels | PROLV000964 | 2.43 | Protein levels | Myeloid | 2 | 3 | 7 | 23 | |
| 1186 | Benign neoplasm, Adipose | MALIG000001 | 2.42 | Malignancy | Adipose | 1 | 2 | 6 | 14 | |
| 1187 | CPM/PCSK9 ratio | PRORT000731 | 2.42 | Protein ratios | Hepatocyte | 71 | 2 | 8 | 13 | |
| 1188 | Supplement use, glucosamine | DTSUP000025 | 2.42 | Diet and Supplement | Neural / glial | 0 | 2 | 7 | 19 | |
| 1189 | GALNT7 levels | PROLV000852 | 2.42 | Protein levels | Myeloid | 81 | 2 | 5 | 9 | |
| 1190 | VSTM2L levels | PROLV002176 | 2.41 | Protein levels | Myeloid | 1 | 2 | 7 | 11 | |
| 1191 | Creativity | PSYCH000003 | 2.40 | Psychiatric | Neural / glial | 10 | 4 | 13 | 23 | |
| 1192 | NTF4 levels | PROLV001443 | 2.39 | Protein levels | Muscle / cardiac | 0 | 2 | 8 | 11 | |
| 1193 | Pulmonary heart disease | CARDI000027 | 2.39 | Cardiac | Hepatocyte | 56 | 3 | 8 | 16 | |
| 1194 | PTGDS levels | PROLV001664 | 2.38 | Protein levels | Renal epithelium | 59 | 0 | 9 | 11 | |
| 1195 | FURIN/INHBC ratio | PRORT001184 | 2.38 | Protein ratios | Hepatocyte | 45 | 1 | 8 | 23 | |
| 1196 | Biliary atresia | HPBIL000002 | 2.38 | Hepatopancreatobiliary | Stromal / connective | 0 | 2 | 8 | 6 | |
| 1197 | TNXB levels | PROLV002085 | 2.38 | Protein levels | Stromal / connective | 56 | 4 | 7 | 22 | |
| 1198 | Total lipids, VLDL | LIPID000077 | 2.38 | Lipids | Hepatocyte | 1,057 | 2 | 8 | 17 | |
| 1199 | PGA4 levels | PROLV001542 | 2.38 | Protein levels | Pancreatic epithelium | 31 | 0 | 7 | 8 | |
| 1200 | NTRK3/SCARF2 ratio | PRORT001604 | 2.38 | Protein ratios | Vascular | 2 | 0 | 9 | 10 | |
| 1201 | IGLL1 levels | PROLV001036 | 2.37 | Protein levels | Muscle / cardiac | 0 | 3 | 8 | 20 | |
| 1202 | Cardiac conduction disorder | CARDI000030 | 2.35 | Cardiac | Muscle / cardiac | 14 | 3 | 6 | 13 | |
| 1203 | GHR levels | PROLV000885 | 2.35 | Protein levels | Hepatocyte | 17 | 2 | 7 | 23 | |
| 1204 | ANXA11 levels | PROLV000106 | 2.35 | Protein levels | Stromal / connective | 26 | 2 | 5 | 15 | |
| 1205 | EREG/GYS1 ratio | PRORT001054 | 2.33 | Protein ratios | Myeloid | 22 | 3 | 14 | 14 | |
| 1206 | SLIT2 levels | PROLV001887 | 2.33 | Protein levels | Neural / glial | 0 | 1 | 7 | 15 | |
| 1207 | HRG levels | PROLV000988 | 2.33 | Protein levels | Neural / glial | 68 | 4 | 12 | 26 | |
| 1208 | CALCOCO1 levels | PROLV000257 | 2.32 | Protein levels | Vascular | 7 | 1 | 2 | 13 | |
| 1209 | Sulfate | METAB000051 | 2.32 | Metabolites | Hematopoietic progenitor | 0 | 1 | 5 | 6 | |
| 1210 | C2/SSC5D ratio | PRORT000265 | 2.32 | Protein ratios | Vascular | 15 | 1 | 6 | 10 | |
| 1211 | Sleep behaviour | BEHAV000016 | 2.32 | Behavioural | Neural / glial | 57 | 4 | 8 | 7 | |
| 1212 | CDKN1A/FOXO1 ratio | PRORT000567 | 2.32 | Protein ratios | Myeloid | 15 | 4 | 11 | 22 | |
| 1213 | FOXO3/MAP3K5 ratio | PRORT001178 | 2.31 | Protein ratios | Gastrointestinal epithelium | 0 | 1 | 11 | 19 | |
| 1214 | Arterial dissection | VASCU000003 | 2.31 | Vascular | Stromal / connective | 16 | 0 | 2 | 15 | |
| 1215 | Paradoxical eczema | IMMUN000036 | 2.30 | Immunologic | Myeloid | 0 | 1 | 6 | 16 | |
| 1216 | APOM/ERBB3 ratio | PRORT000118 | 2.30 | Protein ratios | Hepatocyte | 22 | 1 | 9 | 15 | |
| 1217 | Pregnancy complication, oedema | REPRO000032 | 2.28 | Reproductive | B / plasma cell | 3 | 0 | 3 | 2 | |
| 1218 | Cancer, Colorectal | MALIG000013 | 2.28 | Malignancy | Epithelial | 27 | 0 | 3 | 2 | |
| 1219 | CRYBB2 levels | PROLV000533 | 2.27 | Protein levels | B / plasma cell | 4 | 2 | 6 | 14 | |
| 1220 | Lysophosphatidylcholines | LIPID000054 | 2.26 | Lipids | Neural / glial | 26 | 2 | 4 | 15 | |
| 1221 | Coronary artery calcification | VASCU000055 | 2.26 | Vascular | Vascular | 56 | 4 | 6 | 11 | |
| 1222 | Stomach and duodenal disorder | GASTR000053 | 2.25 | Gastrointestinal | Muscle / cardiac | 6 | 4 | 7 | 18 | |
| 1223 | Age at onset of walking | NEURO000023 | 2.25 | Neurologic | Neural / glial | 11 | 5 | 12 | 21 | |
| 1224 | SPINK4 levels | PROLV001929 | 2.25 | Protein levels | Gastrointestinal epithelium | 25 | 0 | 6 | 11 | |
| 1225 | Knee extension strength | MSKEL000031 | 2.24 | Musculoskeletal | Stromal / connective | 0 | 2 | 6 | 10 | |
| 1226 | Urinary incontinence | NEPHR000014 | 2.24 | Nephrourologic | Epithelial | 1 | 1 | 9 | 9 | |
| 1227 | CDHR2 levels | PROLV000379 | 2.23 | Protein levels | Hepatocyte | 103 | 2 | 13 | 22 | |
| 1228 | BTN2A1/SMOC2 ratio | PRORT000260 | 2.23 | Protein ratios | Myeloid | 49 | 4 | 8 | 21 | |
| 1229 | LILRA5 levels | PROLV001212 | 2.22 | Protein levels | Myeloid | 161 | 2 | 10 | 12 | |
| 1230 | Gut microbial abundance, Holdemania | GASTR000026 | 2.22 | Gastrointestinal | Hepatocyte | 0 | 3 | 13 | 24 | |
| 1231 | NUB1 levels | PROLV001449 | 2.22 | Protein levels | Stromal / connective | 1 | 3 | 7 | 13 | |
| 1232 | LGALS1/LGALS8 ratio | PRORT001449 | 2.22 | Protein ratios | Granulosa cell | 7 | 4 | 12 | 19 | |
| 1233 | PLA2G4A/PPP1R12A ratio | PRORT001673 | 2.22 | Protein ratios | Hepatocyte | 3 | 4 | 10 | 25 | |
| 1234 | CPA1/PRSS2 ratio | PRORT000722 | 2.21 | Protein ratios | Pancreatic epithelium | 17 | 0 | 5 | 9 | |
| 1235 | GFER levels | PROLV000875 | 2.20 | Protein levels | Muscle / cardiac | 1 | 4 | 11 | 27 | |
| 1236 | CCN3/FAP ratio | PRORT000373 | 2.20 | Protein ratios | Hepatocyte | 27 | 4 | 11 | 24 | |
| 1237 | MRAP levels | PROLV001337 | 2.20 | Protein levels | Neural / glial | 0 | 4 | 5 | 19 | |
| 1238 | PHYKPL levels | PROLV001552 | 2.20 | Protein levels | Lymphocyte | 3 | 2 | 6 | 16 | |
| 1239 | CTSO levels | PROLV000567 | 2.19 | Protein levels | Myeloid | 112 | 2 | 11 | 27 | |
| 1240 | Acylcarnitines | METAB000038 | 2.19 | Metabolites | Hepatocyte | 0 | 0 | 0 | 0 | |
| 1241 | Estimated glomerular filtration rate, eGFR | NEPHR000021 | 2.19 | Nephrourologic | Hepatocyte | 2,909 | 2 | 8 | 10 | |
| 1242 | IL1B levels | PROLV001059 | 2.19 | Protein levels | Myeloid | 2 | 3 | 11 | 18 | |
| 1243 | CLEC14A/TNFRSF21 ratio | PRORT000629 | 2.19 | Protein ratios | Neural / glial | 5 | 1 | 1 | 8 | |
| 1244 | Mosaic chromosomal alteration | MISCL000014 | 2.19 | Miscellaneous | Hematopoietic progenitor | 143 | 3 | 12 | 18 | |
| 1245 | Suicidal behaviour | PSYCH000037 | 2.18 | Psychiatric | Neural / glial | 0 | 4 | 8 | 14 | |
| 1246 | SKAP1 levels | PROLV001872 | 2.18 | Protein levels | Lymphocyte | 90 | 2 | 11 | 18 | |
| 1247 | Supplement use, mineral or vitamin, none | DTSUP000027 | 2.18 | Diet and Supplement | Neural / glial | 2 | 5 | 8 | 19 | |
| 1248 | P4HB/PPP1R12A ratio | PRORT001618 | 2.18 | Protein ratios | Muscle / cardiac | 13 | 5 | 11 | 24 | |
| 1249 | FLT3LG levels | PROLV000817 | 2.18 | Protein levels | Hematopoietic progenitor | 69 | 3 | 7 | 12 | |
| 1250 | Cholesteryl esters, LDL | LIPID000017 | 2.17 | Lipids | Hepatocyte | 834 | 1 | 8 | 13 | |
| 1251 | IL1RAP levels | PROLV001062 | 2.17 | Protein levels | Hepatocyte | 96 | 2 | 12 | 13 | |
| 1252 | Serine | METAB000029 | 2.17 | Metabolites | Epithelial | 1 | 4 | 13 | 17 | |
| 1253 | Liver function | HPBIL000021 | 2.15 | Hepatopancreatobiliary | Hepatocyte | 106 | 1 | 7 | 8 | |
| 1254 | Gastrointestinal polyps | GASTR000005 | 2.15 | Gastrointestinal | Respiratory epithelium | 0 | 0 | 4 | 11 | |
| 1255 | TXNDC5 levels | PROLV002125 | 2.15 | Protein levels | Platelet | 15 | 2 | 6 | 20 | |
| 1256 | COL6A3/NBL1 ratio | PRORT000698 | 2.15 | Protein ratios | Stromal / connective | 29 | 2 | 2 | 8 | |
| 1257 | PPP1R14D levels | PROLV001615 | 2.14 | Protein levels | Lymphocyte | 15 | 2 | 14 | 33 | |
| 1258 | Vitamin C | METAB000077 | 2.13 | Metabolites | Lymphocyte | 4 | 2 | 10 | 33 | |
| 1259 | CDKN1A/FXN ratio | PRORT000568 | 2.13 | Protein ratios | Hepatocyte | 19 | 2 | 10 | 18 | |
| 1260 | Pustular skin disorder | DERMA000018 | 2.13 | Dermatologic | Hepatocyte | 0 | 1 | 5 | 13 | |
| 1261 | Pain, limb | MSKEL000037 | 2.13 | Musculoskeletal | B / plasma cell | 1 | 5 | 10 | 20 | |
| 1262 | FOLR2/MSR1 ratio | PRORT001169 | 2.12 | Protein ratios | Myeloid | 40 | 2 | 10 | 11 | |
| 1263 | GGH/INHBC ratio | PRORT001212 | 2.11 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 25 | |
| 1264 | CCBL2 levels | PROLV000274 | 2.11 | Protein levels | Neural / glial | 0 | 0 | 7 | 13 | |
| 1265 | Dietary restriction | DTSUP000009 | 2.11 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 1266 | ROBO2/SCARF2 ratio | PRORT001745 | 2.10 | Protein ratios | Adipose | 12 | 4 | 10 | 12 | |
| 1267 | Infertility | REPRO000010 | 2.09 | Reproductive | Vascular | 0 | 0 | 2 | 9 | |
| 1268 | Erectile dysfunction | VASCU000048 | 2.08 | Vascular | Neural / glial | 0 | 4 | 5 | 15 | |
| 1269 | Medication, vasodilators | VASCU000041 | 2.08 | Vascular | Vascular | 3 | 2 | 5 | 5 | |
| 1270 | GBA1 levels | PROLV000859 | 2.08 | Protein levels | Myeloid | 0 | 2 | 8 | 20 | |
| 1271 | PRKG1 levels | PROLV001633 | 2.07 | Protein levels | Stromal / connective | 10 | 4 | 7 | 15 | |
| 1272 | PNLIPRP1 levels | PROLV001592 | 2.07 | Protein levels | Gastrointestinal epithelium | 89 | 1 | 4 | 7 | |
| 1273 | TDGF1 levels | PROLV002006 | 2.07 | Protein levels | Myeloid | 46 | 2 | 2 | 5 | |
| 1274 | CD300LG/CLEC14A ratio | PRORT000434 | 2.07 | Protein ratios | Vascular | 36 | 3 | 6 | 19 | |
| 1275 | Aplastic anaemia | HEMAT000004 | 2.06 | Hematologic | Muscle / cardiac | 0 | 2 | 5 | 18 | |
| 1276 | Liver fibrosis and cirrhosis | HPBIL000007 | 2.06 | Hepatopancreatobiliary | B / plasma cell | 11 | 4 | 13 | 32 | |
| 1277 | CLEC5A levels | PROLV000455 | 2.06 | Protein levels | Myeloid | 94 | 2 | 9 | 10 | |
| 1278 | Phosphoglycerides | LIPID000063 | 2.06 | Lipids | Hepatocyte | 585 | 3 | 9 | 14 | |
| 1279 | Alcohol use | PSYCH000043 | 2.05 | Psychiatric | Neural / glial | 16 | 4 | 8 | 13 | |
| 1280 | HYOU1/TGFBR3 ratio | PRORT001317 | 2.05 | Protein ratios | Hepatocyte | 27 | 2 | 8 | 23 | |
| 1281 | FCER1A levels | PROLV000776 | 2.04 | Protein levels | Myeloid | 18 | 3 | 21 | 40 | |
| 1282 | CA1/CA2 ratio | PRORT000267 | 2.04 | Protein ratios | Muscle / cardiac | 0 | 1 | 7 | 11 | |
| 1283 | Coronary revascularization | VASCU000059 | 2.03 | Vascular | Vascular | 384 | 4 | 9 | 25 | |
| 1284 | NELL1 levels | PROLV001390 | 2.03 | Protein levels | Renal epithelium | 16 | 0 | 8 | 22 | |
| 1285 | Daytime napping | BEHAV000015 | 2.02 | Behavioural | Neural / glial | 81 | 5 | 11 | 25 | |
| 1286 | ACY1/DCXR ratio | PRORT000019 | 2.02 | Protein ratios | Hepatocyte | 6 | 2 | 10 | 15 | |
| 1287 | NPY/SMOC1 ratio | PRORT001596 | 2.01 | Protein ratios | Hepatocyte | 49 | 2 | 8 | 14 | |
| 1288 | Mononeuropathy | NEURO000027 | 2.01 | Neurologic | Stromal / connective | 2 | 0 | 0 | 3 | |
| 1289 | TFRC levels | PROLV002017 | 2.01 | Protein levels | Myeloid | 70 | 3 | 7 | 24 | |
| 1290 | TSPAN8 levels | PROLV002116 | 2.01 | Protein levels | Hepatocyte | 56 | 1 | 9 | 15 | |
| 1291 | COMP/ITGAV ratio | PRORT000711 | 2.00 | Protein ratios | Myeloid | 58 | 3 | 11 | 18 | |
| 1292 | SRC/TBL1X ratio | PRORT001814 | 2.00 | Protein ratios | Platelet | 1 | 4 | 11 | 15 | |
| 1293 | BANK1/FOXO1 ratio | PRORT000204 | 2.00 | Protein ratios | Muscle / cardiac | 2 | 3 | 9 | 19 | |
| 1294 | APEX1 levels | PROLV000114 | 2.00 | Protein levels | Muscle / cardiac | 6 | 4 | 12 | 38 | |
| 1295 | S100A4/SNAP29 ratio | PRORT001755 | 2.00 | Protein ratios | Hepatocyte | 6 | 1 | 8 | 19 | |
| 1296 | THY1 levels | PROLV002031 | 1.99 | Protein levels | B / plasma cell | 30 | 2 | 10 | 21 | |
| 1297 | EDIL3 levels | PROLV000675 | 1.99 | Protein levels | Lymphocyte | 4 | 2 | 10 | 30 | |
| 1298 | Hair and follicular disorder | DERMA000030 | 1.99 | Dermatologic | Myeloid | 0 | 0 | 2 | 14 | |
| 1299 | Cholines, total | METAB000040 | 1.98 | Metabolites | Hepatocyte | 551 | 3 | 9 | 16 | |
| 1300 | RND3 levels | PROLV001743 | 1.98 | Protein levels | Hepatocyte | 16 | 2 | 10 | 23 | |
| 1301 | FBP1 levels | PROLV000773 | 1.98 | Protein levels | Myeloid | 45 | 4 | 11 | 14 | |
| 1302 | Loneliness | PSYCH000055 | 1.98 | Psychiatric | Neural / glial | 1 | 2 | 10 | 17 | |
| 1303 | Urticaria | IMMUN000007 | 1.98 | Immunologic | Myeloid | 26 | 0 | 0 | 5 | |
| 1304 | GGT1 levels | PROLV000883 | 1.98 | Protein levels | Hepatocyte | 87 | 1 | 5 | 7 | |
| 1305 | Systemic lupus erythematosus, SLE | IMMUN000020 | 1.98 | Immunologic | B / plasma cell | 93 | 2 | 4 | 19 | |
| 1306 | CALCOCO1/DCTN1 ratio | PRORT000294 | 1.97 | Protein ratios | Muscle / cardiac | 0 | 3 | 9 | 21 | |
| 1307 | CXADR/GGT1 ratio | PRORT000812 | 1.97 | Protein ratios | Hepatocyte | 17 | 1 | 4 | 10 | |
| 1308 | ART3/RGMA ratio | PRORT000145 | 1.97 | Protein ratios | Muscle / cardiac | 17 | 3 | 8 | 15 | |
| 1309 | MAPK9 levels | PROLV001271 | 1.97 | Protein levels | Vascular | 0 | 3 | 8 | 17 | |
| 1310 | ADGRE5/VCAM1 ratio | PRORT000034 | 1.97 | Protein ratios | Myeloid | 37 | 4 | 11 | 18 | |
| 1311 | ENO2/TXNDC5 ratio | PRORT001033 | 1.96 | Protein ratios | Hematopoietic progenitor | 6 | 4 | 7 | 18 | |
| 1312 | Benign neoplasm, Melanocytic | MALIG000004 | 1.96 | Malignancy | Stromal / connective | 2 | 0 | 0 | 5 | |
| 1313 | PPP1R14A levels | PROLV001614 | 1.96 | Protein levels | Neural / glial | 11 | 2 | 7 | 11 | |
| 1314 | CNTN3/NCS1 ratio | PRORT000687 | 1.95 | Protein ratios | Hepatocyte | 45 | 1 | 8 | 16 | |
| 1315 | Frailty, unhealthy lifestyle | BEHAV000002 | 1.95 | Behavioural | Myeloid | 5 | 5 | 9 | 16 | |
| 1316 | ZBTB16 levels | PROLV002209 | 1.95 | Protein levels | Muscle / cardiac | 43 | 3 | 6 | 15 | |
| 1317 | ANPEP/CXADR ratio | PRORT000100 | 1.95 | Protein ratios | Vascular | 11 | 3 | 12 | 10 | |
| 1318 | PLAU levels | PROLV001572 | 1.95 | Protein levels | Hepatocyte | 111 | 3 | 7 | 20 | |
| 1319 | Intraocular pressure | OPHTH000011 | 1.94 | Ophthalmic | Stromal / connective | 184 | 4 | 6 | 10 | |
| 1320 | CD27/TNFRSF13B ratio | PRORT000418 | 1.94 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 23 | |
| 1321 | MINK1 levels | PROLV001316 | 1.93 | Protein levels | Stromal / connective | 2 | 4 | 6 | 15 | |
| 1322 | SDK2 levels | PROLV001800 | 1.93 | Protein levels | Myeloid | 29 | 3 | 14 | 24 | |
| 1323 | PVR levels | PROLV001687 | 1.93 | Protein levels | Hepatocyte | 54 | 1 | 9 | 10 | |
| 1324 | SYT1 levels | PROLV001985 | 1.93 | Protein levels | Granulosa cell | 25 | 1 | 6 | 12 | |
| 1325 | NUCB2/TXNDC5 ratio | PRORT001608 | 1.93 | Protein ratios | Hepatocyte | 4 | 3 | 8 | 13 | |
| 1326 | PROC levels | PROLV001637 | 1.93 | Protein levels | Hepatocyte | 164 | 2 | 6 | 14 | |
| 1327 | PDCD6 levels | PROLV001518 | 1.92 | Protein levels | Muscle / cardiac | 54 | 3 | 13 | 24 | |
| 1328 | S100A11/SERPINB8 ratio | PRORT001754 | 1.92 | Protein ratios | Myeloid | 17 | 3 | 8 | 13 | |
| 1329 | DNAJB1/SIRT2 ratio | PRORT000929 | 1.92 | Protein ratios | Hepatocyte | 54 | 1 | 9 | 7 | |
| 1330 | GFRA3 levels | PROLV000878 | 1.92 | Protein levels | Myeloid | 91 | 1 | 8 | 21 | |
| 1331 | MPHOSPH8/PSRC1 ratio | PRORT001554 | 1.92 | Protein ratios | Myeloid | 0 | 5 | 11 | 16 | |
| 1332 | Vitamin E | METAB000079 | 1.91 | Metabolites | Hepatocyte | 2 | 1 | 5 | 12 | |
| 1333 | HMOX2 levels | PROLV000979 | 1.91 | Protein levels | Muscle / cardiac | 52 | 2 | 7 | 13 | |
| 1334 | Knee derangements | MSKEL000016 | 1.91 | Musculoskeletal | Stromal / connective | 5 | 1 | 2 | 7 | |
| 1335 | GSTA1/PBLD ratio | PRORT001250 | 1.91 | Protein ratios | Hepatocyte | 65 | 3 | 13 | 30 | |
| 1336 | CDKN1A/NCK2 ratio | PRORT000570 | 1.91 | Protein ratios | Vascular | 14 | 2 | 9 | 17 | |
| 1337 | Flavour preference | DTSUP000022 | 1.90 | Diet and Supplement | Neural / glial | 94 | 3 | 8 | 18 | |
| 1338 | ZNRF4 levels | PROLV002214 | 1.90 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 1339 | Abnormal heart sounds | CARDI000051 | 1.90 | Cardiac | Muscle / cardiac | 19 | 4 | 6 | 14 | |
| 1340 | Thrombocytopenia | HEMAT000026 | 1.90 | Hematologic | Myeloid | 52 | 1 | 2 | 7 | |
| 1341 | HNRNPAB levels | PROLV000981 | 1.90 | Protein levels | Granulosa cell | 11 | 3 | 8 | 17 | |
| 1342 | CFD levels | PROLV000412 | 1.89 | Protein levels | Myeloid | 9 | 0 | 6 | 14 | |
| 1343 | PALM levels | PROLV001489 | 1.89 | Protein levels | Granulosa cell | 28 | 1 | 7 | 8 | |
| 1344 | APP/HBEGF ratio | PRORT000126 | 1.89 | Protein ratios | Myeloid | 46 | 5 | 17 | 26 | |
| 1345 | Dietary preference | DTSUP000008 | 1.88 | Diet and Supplement | Neural / glial | 53 | 3 | 7 | 12 | |
| 1346 | CD46/NECTIN2 ratio | PRORT000456 | 1.88 | Protein ratios | Vascular | 26 | 3 | 7 | 16 | |
| 1347 | Gynaecomastia | BREAS000003 | 1.88 | Breast | Granulosa cell | 0 | 1 | 4 | 11 | |
| 1348 | IGFBP6/SMOC2 ratio | PRORT001338 | 1.88 | Protein ratios | Adipose | 2 | 3 | 8 | 13 | |
| 1349 | COL5A1 levels | PROLV000491 | 1.87 | Protein levels | Myeloid | 47 | 1 | 6 | 11 | |
| 1350 | CA14 levels | PROLV000243 | 1.87 | Protein levels | Muscle / cardiac | 52 | 2 | 7 | 12 | |
| 1351 | AXIN1/MAVS ratio | PRORT000175 | 1.87 | Protein ratios | Neural / glial | 6 | 3 | 16 | 35 | |
| 1352 | ADGRD1 levels | PROLV000041 | 1.87 | Protein levels | Hepatocyte | 47 | 5 | 12 | 15 | |
| 1353 | Cardiovascular disease, none | CARDI000034 | 1.86 | Cardiac | Vascular | 201 | 2 | 5 | 9 | |
| 1354 | CNTNAP2/DPP10 ratio | PRORT000689 | 1.86 | Protein ratios | Vascular | 0 | 1 | 4 | 9 | |
| 1355 | Ketone bodies | METAB000056 | 1.86 | Metabolites | Hepatocyte | 118 | 1 | 6 | 7 | |
| 1356 | CKMT1A or CKMT1B levels | PROLV000442 | 1.86 | Protein levels | Gastrointestinal epithelium | 59 | 0 | 10 | 7 | |
| 1357 | Cancer, General | MALIG000015 | 1.85 | Malignancy | Myeloid | 29 | 0 | 1 | 2 | |
| 1358 | HMBS/PKLR ratio | PRORT001288 | 1.85 | Protein ratios | Lymphocyte | 29 | 1 | 15 | 23 | |
| 1359 | Medication, hypnotic or sedative | PSYCH000020 | 1.84 | Psychiatric | Neural / glial | 1 | 5 | 14 | 26 | |
| 1360 | COQ7 levels | PROLV000498 | 1.84 | Protein levels | Hepatocyte | 59 | 1 | 6 | 7 | |
| 1361 | APOM levels | PROLV000128 | 1.84 | Protein levels | Hepatocyte | 122 | 2 | 8 | 20 | |
| 1362 | Family history, Alzheimer disease | NEURO000007 | 1.83 | Neurologic | Vascular | 35 | 0 | 1 | 3 | |
| 1363 | ITGA2 levels | PROLV001105 | 1.83 | Protein levels | Vascular | 76 | 3 | 13 | 27 | |
| 1364 | VEGFA levels | PROLV002157 | 1.83 | Protein levels | Muscle / cardiac | 30 | 1 | 5 | 14 | |
| 1365 | FLT1/TGFB1 ratio | PRORT001163 | 1.82 | Protein ratios | Stromal / connective | 7 | 4 | 10 | 15 | |
| 1366 | Risk-taking behaviour | BEHAV000013 | 1.82 | Behavioural | Neural / glial | 77 | 5 | 7 | 24 | |
| 1367 | Operation, urological | NEPHR000016 | 1.82 | Nephrourologic | Vascular | 16 | 0 | 6 | 18 | |
| 1368 | CST3/EFEMP1 ratio | PRORT000782 | 1.81 | Protein ratios | Hepatocyte | 26 | 1 | 6 | 15 | |
| 1369 | DKKL1 levels | PROLV000623 | 1.81 | Protein levels | Hepatocyte | 77 | 4 | 10 | 25 | |
| 1370 | Retinal detachments and defects | OPHTH000039 | 1.81 | Ophthalmic | Stromal / connective | 2 | 3 | 7 | 22 | |
| 1371 | KRT19 levels | PROLV001166 | 1.81 | Protein levels | Respiratory epithelium | 46 | 0 | 11 | 7 | |
| 1372 | CD160/KLRB1 ratio | PRORT000377 | 1.81 | Protein ratios | Lymphocyte | 2 | 2 | 13 | 20 | |
| 1373 | Fatty acids, omega-3 | LIPID000024 | 1.81 | Lipids | Hepatocyte | 605 | 2 | 9 | 17 | |
| 1374 | Supplement use, dietary | DTSUP000024 | 1.81 | Diet and Supplement | Neural / glial | 7 | 5 | 10 | 20 | |
| 1375 | Lymphangioleiomyomatosis | RESPI000014 | 1.80 | Respiratory | Muscle / cardiac | 0 | 3 | 7 | 25 | |
| 1376 | TFF3 levels | PROLV002014 | 1.79 | Protein levels | Pancreatic epithelium | 24 | 0 | 3 | 5 | |
| 1377 | BCAT1 levels | PROLV000183 | 1.79 | Protein levels | Stromal / connective | 43 | 3 | 9 | 26 | |
| 1378 | APOF levels | PROLV000125 | 1.79 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 1379 | CD33 levels | PROLV000335 | 1.79 | Protein levels | Myeloid | 63 | 3 | 12 | 31 | |
| 1380 | ARHGEF10 levels | PROLV000140 | 1.79 | Protein levels | Stromal / connective | 25 | 7 | 14 | 21 | |
| 1381 | PENK levels | PROLV001535 | 1.78 | Protein levels | Myeloid | 19 | 1 | 4 | 11 | |
| 1382 | IGSF8/NECTIN2 ratio | PRORT001339 | 1.77 | Protein ratios | Granulosa cell | 15 | 1 | 14 | 37 | |
| 1383 | Abdominal aortic calcification | VASCU000051 | 1.76 | Vascular | Vascular | 0 | 1 | 4 | 11 | |
| 1384 | COMP/DPP4 ratio | PRORT000709 | 1.76 | Protein ratios | Myeloid | 32 | 4 | 13 | 18 | |
| 1385 | PALM2 levels | PROLV001490 | 1.76 | Protein levels | Lymphocyte | 22 | 4 | 19 | 36 | |
| 1386 | CCL28/PDGFB ratio | PRORT000354 | 1.75 | Protein ratios | Hematopoietic progenitor | 0 | 3 | 6 | 27 | |
| 1387 | DAPK2 levels | PROLV000593 | 1.74 | Protein levels | Myeloid | 21 | 3 | 9 | 7 | |
| 1388 | PDLIM7/PLA2G4A ratio | PRORT001654 | 1.74 | Protein ratios | Platelet | 8 | 4 | 5 | 18 | |
| 1389 | GUSB levels | PROLV000946 | 1.72 | Protein levels | Hepatocyte | 109 | 2 | 9 | 12 | |
| 1390 | HMBS/UBAC1 ratio | PRORT001290 | 1.72 | Protein ratios | Muscle / cardiac | 9 | 1 | 8 | 5 | |
| 1391 | Hearing aid use | AUDIO000011 | 1.72 | Auditory | Epithelial | 12 | 1 | 5 | 9 | |
| 1392 | CNTN1/EGFR ratio | PRORT000685 | 1.72 | Protein ratios | Hepatocyte | 69 | 2 | 10 | 12 | |
| 1393 | CCN1/DNAJB1 ratio | PRORT000361 | 1.72 | Protein ratios | Hepatocyte | 26 | 4 | 14 | 37 | |
| 1394 | SSC5D levels | PROLV001948 | 1.72 | Protein levels | Vascular | 40 | 3 | 14 | 12 | |
| 1395 | Arterial thrombosis | VASCU000005 | 1.72 | Vascular | Vascular | 0 | 0 | 7 | 21 | |
| 1396 | ENO1 levels | PROLV000705 | 1.71 | Protein levels | Myeloid | 5 | 4 | 8 | 15 | |
| 1397 | CPXM1/HBEGF ratio | PRORT000733 | 1.71 | Protein ratios | Myeloid | 44 | 4 | 11 | 22 | |
| 1398 | CDH1 levels | PROLV000371 | 1.71 | Protein levels | Gastrointestinal epithelium | 18 | 0 | 10 | 5 | |
| 1399 | LCAT levels | PROLV001190 | 1.71 | Protein levels | Hepatocyte | 88 | 2 | 8 | 13 | |
| 1400 | WAS levels | PROLV002184 | 1.70 | Protein levels | Hepatocyte | 25 | 2 | 6 | 11 | |
| 1401 | CPA1/CTRC ratio | PRORT000720 | 1.70 | Protein ratios | Pancreatic epithelium | 38 | 0 | 1 | 5 | |
| 1402 | GLOD4/HSPA1A ratio | PRORT001218 | 1.70 | Protein ratios | Myeloid | 20 | 4 | 13 | 19 | |
| 1403 | GYS1/PPP1R2 ratio | PRORT001255 | 1.70 | Protein ratios | Melanocyte | 0 | 1 | 5 | 12 | |
| 1404 | MED18/SMAD1 ratio | PRORT001509 | 1.70 | Protein ratios | Hepatocyte | 2 | 4 | 15 | 37 | |
| 1405 | C1RL levels | PROLV000228 | 1.69 | Protein levels | Hepatocyte | 59 | 2 | 7 | 10 | |
| 1406 | HYOU1/ROR1 ratio | PRORT001316 | 1.69 | Protein ratios | Hepatocyte | 41 | 1 | 6 | 6 | |
| 1407 | Lifespan | AGING000006 | 1.69 | Aging | Neural / glial | 2 | 1 | 9 | 10 | |
| 1408 | Macular degeneration | OPHTH000036 | 1.68 | Ophthalmic | Hepatocyte | 106 | 2 | 7 | 15 | |
| 1409 | CTSZ/HSPG2 ratio | PRORT000804 | 1.68 | Protein ratios | Hepatocyte | 35 | 5 | 12 | 20 | |
| 1410 | Lysine metabolites | METAB000009 | 1.68 | Metabolites | Lymphocyte | 6 | 1 | 3 | 20 | |
| 1411 | FST levels | PROLV000829 | 1.67 | Protein levels | Granulosa cell | 34 | 2 | 6 | 15 | |
| 1412 | Urinary albumin | NEPHR000020 | 1.67 | Nephrourologic | Vascular | 29 | 2 | 10 | 12 | |
| 1413 | Non-cancer illness burden | MISCL000029 | 1.67 | Miscellaneous | Neural / glial | 24 | 5 | 8 | 15 | |
| 1414 | Gastrointestinal endoscopy | GASTR000042 | 1.67 | Gastrointestinal | Neural / glial | 13 | 2 | 8 | 11 | |
| 1415 | DLL4 levels | PROLV000627 | 1.66 | Protein levels | Epithelial | 2 | 1 | 10 | 16 | |
| 1416 | HYOU1/THBD ratio | PRORT001318 | 1.66 | Protein ratios | Hepatocyte | 54 | 2 | 7 | 23 | |
| 1417 | AGRN/BTN2A1 ratio | PRORT000046 | 1.64 | Protein ratios | Adipose | 70 | 2 | 7 | 7 | |
| 1418 | GRAP2/MAP4K5 ratio | PRORT001241 | 1.64 | Protein ratios | Lymphocyte | 10 | 2 | 13 | 30 | |
| 1419 | IL18BP/ROR1 ratio | PRORT001346 | 1.64 | Protein ratios | Myeloid | 6 | 3 | 14 | 30 | |
| 1420 | CD55 levels | PROLV000345 | 1.64 | Protein levels | Adipose | 54 | 0 | 9 | 16 | |
| 1421 | DOK2/GRAP2 ratio | PRORT000938 | 1.64 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 4 | 7 | |
| 1422 | NEO1 levels | PROLV001392 | 1.64 | Protein levels | Muscle / cardiac | 0 | 3 | 11 | 19 | |
| 1423 | CALCOCO1/CASP3 ratio | PRORT000291 | 1.64 | Protein ratios | Myeloid | 0 | 4 | 11 | 21 | |
| 1424 | Pregnancy complication, obstructed labour | REPRO000031 | 1.63 | Reproductive | Stromal / connective | 0 | 3 | 6 | 11 | |
| 1425 | Mental disorder | PSYCH000013 | 1.63 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 1426 | Sun exposure | BEHAV000001 | 1.63 | Behavioural | Neural / glial | 80 | 3 | 7 | 21 | |
| 1427 | AMBP/HYOU1 ratio | PRORT000087 | 1.62 | Protein ratios | Hepatocyte | 91 | 2 | 6 | 9 | |
| 1428 | AIFM1/PLXNA4 ratio | PRORT000060 | 1.62 | Protein ratios | Hepatocyte | 9 | 2 | 10 | 26 | |
| 1429 | SCGB3A2 levels | PROLV001788 | 1.62 | Protein levels | Respiratory epithelium | 35 | 2 | 9 | 16 | |
| 1430 | Phosphatidylethanolamines | LIPID000059 | 1.61 | Lipids | Hepatocyte | 24 | 0 | 1 | 3 | |
| 1431 | DYNLL1 levels | PROLV000666 | 1.61 | Protein levels | B / plasma cell | 0 | 1 | 4 | 4 | |
| 1432 | TIMP3/ZBTB16 ratio | PRORT001838 | 1.59 | Protein ratios | Vascular | 1 | 2 | 7 | 20 | |
| 1433 | Endometriosis | REPRO000005 | 1.59 | Reproductive | Stromal / connective | 49 | 1 | 4 | 8 | |
| 1434 | SERPINA12 levels | PROLV001816 | 1.59 | Protein levels | Hepatocyte | 63 | 3 | 11 | 18 | |
| 1435 | NECTIN2/SDC1 ratio | PRORT001578 | 1.59 | Protein ratios | Hepatocyte | 59 | 1 | 11 | 9 | |
| 1436 | C1R levels | PROLV000227 | 1.58 | Protein levels | Hepatocyte | 0 | 4 | 15 | 29 | |
| 1437 | MYOC/RGMB ratio | PRORT001567 | 1.57 | Protein ratios | Vascular | 11 | 2 | 8 | 15 | |
| 1438 | BCAN/MOG ratio | PRORT000217 | 1.57 | Protein ratios | Myeloid | 5 | 1 | 6 | 12 | |
| 1439 | Bile acid metabolites | METAB000033 | 1.57 | Metabolites | Hepatocyte | 8 | 1 | 5 | 15 | |
| 1440 | CD300C/LRRC25 ratio | PRORT000426 | 1.57 | Protein ratios | Myeloid | 55 | 2 | 7 | 10 | |
| 1441 | COL1A1/SOST ratio | PRORT000694 | 1.57 | Protein ratios | Myeloid | 15 | 1 | 2 | 5 | |
| 1442 | CD58/MEGF10 ratio | PRORT000477 | 1.57 | Protein ratios | Muscle / cardiac | 15 | 5 | 19 | 37 | |
| 1443 | INSL5 levels | PROLV001093 | 1.57 | Protein levels | Hematopoietic progenitor | 10 | 1 | 5 | 7 | |
| 1444 | ATXN10/CASP10 ratio | PRORT000161 | 1.56 | Protein ratios | Granulosa cell | 1 | 4 | 9 | 24 | |
| 1445 | FABP5/PPCDC ratio | PRORT001102 | 1.56 | Protein ratios | Stromal / connective | 1 | 4 | 5 | 12 | |
| 1446 | IL31RA levels | PROLV001071 | 1.56 | Protein levels | Granulosa cell | 1 | 3 | 7 | 13 | |
| 1447 | Alzheimer disease | NEURO000018 | 1.56 | Neurologic | Myeloid | 182 | 2 | 8 | 9 | |
| 1448 | SMAD5 levels | PROLV001897 | 1.55 | Protein levels | Myeloid | 95 | 2 | 6 | 11 | |
| 1449 | MSTN levels | PROLV001345 | 1.54 | Protein levels | Muscle / cardiac | 17 | 2 | 9 | 17 | |
| 1450 | CA2/HMBS ratio | PRORT000275 | 1.54 | Protein ratios | Lymphocyte | 4 | 1 | 13 | 42 | |
| 1451 | AGRN/CRIM1 ratio | PRORT000047 | 1.54 | Protein ratios | Adipose | 8 | 3 | 11 | 13 | |
| 1452 | PDLIM7/SRC ratio | PRORT001655 | 1.53 | Protein ratios | Myeloid | 12 | 3 | 7 | 20 | |
| 1453 | CETN3 levels | PROLV000409 | 1.53 | Protein levels | Platelet | 15 | 3 | 5 | 14 | |
| 1454 | Cutaneous cysts and sinuses | DERMA000002 | 1.53 | Dermatologic | Cutaneous epithelium | 30 | 0 | 13 | 20 | |
| 1455 | KIFBP/LYN ratio | PRORT001403 | 1.53 | Protein ratios | Myeloid | 9 | 4 | 14 | 37 | |
| 1456 | ADIPOQ levels | PROLV000050 | 1.52 | Protein levels | Muscle / cardiac | 76 | 3 | 7 | 18 | |
| 1457 | PRDX3 levels | PROLV001625 | 1.52 | Protein levels | Myeloid | 11 | 2 | 7 | 12 | |
| 1458 | ADAMTS15 levels | PROLV000032 | 1.52 | Protein levels | Hepatocyte | 42 | 1 | 7 | 9 | |
| 1459 | COL6A3/COLEC12 ratio | PRORT000695 | 1.51 | Protein ratios | Adipose | 53 | 4 | 9 | 18 | |
| 1460 | Ventricular outflow tract obstruction | CARDI000032 | 1.51 | Cardiac | Muscle / cardiac | 0 | 2 | 13 | 27 | |
| 1461 | CD300E/LILRA5 ratio | PRORT000432 | 1.51 | Protein ratios | Myeloid | 25 | 4 | 12 | 19 | |
| 1462 | Substance use | PSYCH000049 | 1.50 | Psychiatric | Muscle / cardiac | 0 | 4 | 6 | 14 | |
| 1463 | Shoulder lesion | MSKEL000068 | 1.50 | Musculoskeletal | B / plasma cell | 22 | 1 | 5 | 15 | |
| 1464 | PSME2/RBKS ratio | PRORT001713 | 1.49 | Protein ratios | Hepatocyte | 23 | 4 | 15 | 13 | |
| 1465 | PCDH17/PTPRM ratio | PRORT001624 | 1.49 | Protein ratios | Vascular | 0 | 3 | 9 | 17 | |
| 1466 | AOC3 levels | PROLV000109 | 1.48 | Protein levels | Myeloid | 116 | 4 | 13 | 22 | |
| 1467 | MANF/PTPN6 ratio | PRORT001479 | 1.48 | Protein ratios | Muscle / cardiac | 9 | 1 | 5 | 13 | |
| 1468 | Retinal vascular morphology | OPHTH000045 | 1.48 | Ophthalmic | Vascular | 253 | 2 | 5 | 7 | |
| 1469 | EDAR/TACC3 ratio | PRORT000980 | 1.48 | Protein ratios | Myeloid | 9 | 3 | 14 | 21 | |
| 1470 | Medication use | MISCL000037 | 1.47 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 1471 | CA2/TGM2 ratio | PRORT000278 | 1.47 | Protein ratios | Epithelial | 17 | 3 | 7 | 15 | |
| 1472 | IGFBP6 levels | PROLV001032 | 1.47 | Protein levels | Hepatocyte | 24 | 1 | 5 | 7 | |
| 1473 | GASK1A levels | PROLV000856 | 1.47 | Protein levels | Hepatocyte | 49 | 1 | 4 | 10 | |
| 1474 | CD74/IL18BP ratio | PRORT000503 | 1.46 | Protein ratios | Myeloid | 54 | 2 | 5 | 12 | |
| 1475 | Lactase deficiency | METBL000002 | 1.46 | Metabolic | Vascular | 0 | 2 | 5 | 12 | |
| 1476 | SOST levels | PROLV001922 | 1.46 | Protein levels | Myeloid | 33 | 1 | 5 | 9 | |
| 1477 | CDKN1A/YES1 ratio | PRORT000576 | 1.46 | Protein ratios | Muscle / cardiac | 8 | 4 | 11 | 28 | |
| 1478 | Tendinitis | MSKEL000070 | 1.46 | Musculoskeletal | Neural / glial | 0 | 1 | 3 | 9 | |
| 1479 | CDKN1A/DAB2 ratio | PRORT000565 | 1.46 | Protein ratios | Hepatocyte | 21 | 3 | 12 | 27 | |
| 1480 | MAVS/PPP1R9B ratio | PRORT001498 | 1.45 | Protein ratios | Adipose | 0 | 3 | 12 | 33 | |
| 1481 | MINPP1 levels | PROLV001317 | 1.45 | Protein levels | Neural / glial | 0 | 5 | 15 | 23 | |
| 1482 | Triglycerides/phosphoglycerides | LIPID000042 | 1.45 | Lipids | Hepatocyte | 839 | 3 | 8 | 17 | |
| 1483 | FADD/LACTB2 ratio | PRORT001104 | 1.45 | Protein ratios | Hematopoietic progenitor | 1 | 1 | 8 | 6 | |
| 1484 | EDAR/ERBIN ratio | PRORT000967 | 1.44 | Protein ratios | Myeloid | 31 | 4 | 15 | 24 | |
| 1485 | CD163/ICAM1 ratio | PRORT000381 | 1.44 | Protein ratios | Myeloid | 21 | 5 | 19 | 38 | |
| 1486 | Negative affect | PSYCH000030 | 1.44 | Psychiatric | Neural / glial | 83 | 3 | 8 | 9 | |
| 1487 | Catecholamine metabolites | METAB000070 | 1.44 | Metabolites | Vascular | 0 | 1 | 3 | 6 | |
| 1488 | Pregnancy complication, abortive | REPRO000027 | 1.44 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 1489 | PON3 levels | PROLV001602 | 1.43 | Protein levels | Hepatocyte | 81 | 4 | 9 | 26 | |
| 1490 | ADHD | PSYCH000033 | 1.42 | Psychiatric | Hematopoietic progenitor | 15 | 3 | 3 | 9 | |
| 1491 | ENO2/HCLS1 ratio | PRORT001023 | 1.42 | Protein ratios | Myeloid | 13 | 2 | 11 | 16 | |
| 1492 | TNFRSF11A levels | PROLV002060 | 1.41 | Protein levels | B / plasma cell | 31 | 1 | 4 | 8 | |
| 1493 | LHPP levels | PROLV001209 | 1.41 | Protein levels | Lymphocyte | 19 | 2 | 14 | 44 | |
| 1494 | HYOU1 levels | PROLV001002 | 1.41 | Protein levels | Hepatocyte | 168 | 1 | 4 | 14 | |
| 1495 | Intelligence decline | PSYCH000005 | 1.41 | Psychiatric | Lymphocyte | 0 | 4 | 10 | 39 | |
| 1496 | CXCL1 levels | PROLV000575 | 1.40 | Protein levels | Granulosa cell | 44 | 2 | 6 | 9 | |
| 1497 | INHBC levels | PROLV001088 | 1.40 | Protein levels | Hepatocyte | 91 | 2 | 8 | 18 | |
| 1498 | BCAM/LGALS4 ratio | PRORT000210 | 1.40 | Protein ratios | Hepatocyte | 31 | 1 | 7 | 4 | |
| 1499 | Smoking effects on COPD x smoking interaction | RESPI000013 | 1.40 | Respiratory | Hepatocyte | 21 | 0 | 4 | 7 | |
| 1500 | ITGB1BP2/STAT5B ratio | PRORT001388 | 1.40 | Protein ratios | Muscle / cardiac | 13 | 2 | 7 | 24 | |
| 1501 | SGSH levels | PROLV001850 | 1.39 | Protein levels | Myeloid | 70 | 3 | 11 | 22 | |
| 1502 | BIN2/EREG ratio | PRORT000231 | 1.39 | Protein ratios | Myeloid | 12 | 2 | 7 | 24 | |
| 1503 | CIAPIN1 levels | PROLV000435 | 1.39 | Protein levels | Lymphocyte | 1 | 5 | 9 | 35 | |
| 1504 | CRADD/FKBP4 ratio | PRORT000746 | 1.39 | Protein ratios | Hepatocyte | 7 | 2 | 7 | 14 | |
| 1505 | ITGB1/NCAM1 ratio | PRORT001378 | 1.39 | Protein ratios | Hepatocyte | 41 | 4 | 10 | 22 | |
| 1506 | CYTL1 levels | PROLV000589 | 1.39 | Protein levels | Stromal / connective | 2 | 2 | 4 | 6 | |
| 1507 | Haematocrit | HEMAT000006 | 1.38 | Hematologic | Hepatocyte | 2,782 | 1 | 7 | 9 | |
| 1508 | Medication, calcium channel blocker | VASCU000035 | 1.38 | Vascular | Vascular | 18 | 1 | 4 | 14 | |
| 1509 | Electrolyte disorder | METBL000004 | 1.38 | Metabolic | Hepatocyte | 5 | 0 | 5 | 10 | |
| 1510 | CLEC4G/KEL ratio | PRORT000659 | 1.38 | Protein ratios | Myeloid | 43 | 2 | 12 | 33 | |
| 1511 | CXCL11/CXCL13 ratio | PRORT000816 | 1.37 | Protein ratios | Myeloid | 18 | 4 | 10 | 17 | |
| 1512 | IGSF3 levels | PROLV001038 | 1.37 | Protein levels | Hepatocyte | 95 | 2 | 8 | 28 | |
| 1513 | NXPH3 levels | PROLV001458 | 1.37 | Protein levels | Stromal / connective | 3 | 1 | 4 | 15 | |
| 1514 | CTF1 levels | PROLV000555 | 1.37 | Protein levels | Myeloid | 5 | 2 | 8 | 16 | |
| 1515 | ABHD14B/SCRN1 ratio | PRORT000006 | 1.37 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 7 | 10 | |
| 1516 | Bone infection | IMMUN000053 | 1.37 | Immunologic | Myeloid | 0 | 3 | 10 | 24 | |
| 1517 | WARS levels | PROLV002183 | 1.36 | Protein levels | Lymphocyte | 52 | 3 | 12 | 28 | |
| 1518 | CD4 levels | PROLV000339 | 1.36 | Protein levels | Myeloid | 82 | 2 | 7 | 15 | |
| 1519 | Gastric ulcer | GASTR000048 | 1.36 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 1520 | CTRB1/PLA2G1B ratio | PRORT000795 | 1.36 | Protein ratios | Pancreatic epithelium | 18 | 0 | 2 | 6 | |
| 1521 | Chronic viral hepatitis | IMMUN000056 | 1.36 | Immunologic | Stromal / connective | 4 | 0 | 1 | 7 | |
| 1522 | TIRAP levels | PROLV002042 | 1.36 | Protein levels | Hepatocyte | 1 | 2 | 7 | 14 | |
| 1523 | Skin pigmentation | DERMA000026 | 1.36 | Dermatologic | Melanocyte | 78 | 1 | 1 | 3 | |
| 1524 | Epigenetic age acceleration | AGING000002 | 1.35 | Aging | Hematopoietic progenitor | 25 | 1 | 3 | 22 | |
| 1525 | CD34 levels | PROLV000336 | 1.35 | Protein levels | Stromal / connective | 67 | 3 | 10 | 21 | |
| 1526 | ACVRL1/TNFRSF10B ratio | PRORT000016 | 1.35 | Protein ratios | Myeloid | 40 | 3 | 11 | 16 | |
| 1527 | OLR1 levels | PROLV001467 | 1.35 | Protein levels | Myeloid | 37 | 2 | 7 | 17 | |
| 1528 | GP5 levels | PROLV000916 | 1.35 | Protein levels | Lymphocyte | 1 | 4 | 10 | 27 | |
| 1529 | TNFRSF12A levels | PROLV002062 | 1.35 | Protein levels | Epithelial | 11 | 0 | 7 | 6 | |
| 1530 | Medication, antiplatelet | VASCU000032 | 1.34 | Vascular | Vascular | 78 | 1 | 5 | 9 | |
| 1531 | CPA1 levels | PROLV000501 | 1.34 | Protein levels | Pancreatic epithelium | 139 | 0 | 6 | 6 | |
| 1532 | Peptic ulcer disease | GASTR000051 | 1.34 | Gastrointestinal | Vascular | 12 | 0 | 1 | 5 | |
| 1533 | TMPRSS15 levels | PROLV002049 | 1.34 | Protein levels | Myeloid | 35 | 2 | 9 | 16 | |
| 1534 | GYS1/TIA1 ratio | PRORT001256 | 1.34 | Protein ratios | Hepatocyte | 13 | 3 | 12 | 19 | |
| 1535 | PSMG3 levels | PROLV001660 | 1.34 | Protein levels | Muscle / cardiac | 21 | 3 | 10 | 24 | |
| 1536 | TIA1/USP8 ratio | PRORT001837 | 1.34 | Protein ratios | Hepatocyte | 12 | 3 | 11 | 37 | |
| 1537 | CD163/DSC2 ratio | PRORT000379 | 1.34 | Protein ratios | Hepatocyte | 19 | 3 | 14 | 13 | |
| 1538 | CLEC14A/EPHB4 ratio | PRORT000626 | 1.33 | Protein ratios | Vascular | 10 | 3 | 7 | 17 | |
| 1539 | DNAJB14 levels | PROLV000631 | 1.33 | Protein levels | Muscle / cardiac | 12 | 2 | 3 | 16 | |
| 1540 | ELOA/POLR2F ratio | PRORT001016 | 1.32 | Protein ratios | Muscle / cardiac | 0 | 3 | 16 | 28 | |
| 1541 | CEACAM1 levels | PROLV000387 | 1.32 | Protein levels | Hepatocyte | 47 | 1 | 6 | 11 | |
| 1542 | CKAP4/IL4R ratio | PRORT000620 | 1.32 | Protein ratios | Hepatocyte | 33 | 2 | 13 | 18 | |
| 1543 | FXN/TRIAP1 ratio | PRORT001195 | 1.32 | Protein ratios | Myeloid | 1 | 2 | 6 | 11 | |
| 1544 | Phospholipids, HDL | LIPID000048 | 1.32 | Lipids | Hepatocyte | 2,061 | 3 | 9 | 16 | |
| 1545 | CLIP2/DNAJA2 ratio | PRORT000665 | 1.31 | Protein ratios | Muscle / cardiac | 0 | 3 | 10 | 18 | |
| 1546 | BCAM/ICAM4 ratio | PRORT000209 | 1.31 | Protein ratios | Hematopoietic progenitor | 1 | 3 | 9 | 21 | |
| 1547 | Hypertensive chronic kidney disease | NEPHR000002 | 1.31 | Nephrourologic | Hepatocyte | 12 | 1 | 5 | 12 | |
| 1548 | FUT3 levels | PROLV000837 | 1.31 | Protein levels | Neural / glial | 2 | 2 | 5 | 17 | |
| 1549 | CD300LG levels | PROLV000333 | 1.31 | Protein levels | Vascular | 83 | 1 | 4 | 13 | |
| 1550 | CKB levels | PROLV000440 | 1.31 | Protein levels | Muscle / cardiac | 40 | 3 | 5 | 15 | |
| 1551 | Respiratory insufficiency | RESPI000031 | 1.30 | Respiratory | Hepatocyte | 0 | 4 | 10 | 29 | |
| 1552 | DBNL/HEXIM1 ratio | PRORT000866 | 1.30 | Protein ratios | Muscle / cardiac | 0 | 2 | 8 | 15 | |
| 1553 | MAP3K5/ZBTB16 ratio | PRORT001489 | 1.30 | Protein ratios | Muscle / cardiac | 10 | 5 | 9 | 25 | |
| 1554 | Impacted cerumen | AUDIO000002 | 1.30 | Auditory | Salivary epithelium | 1 | 1 | 8 | 14 | |
| 1555 | MME levels | PROLV001320 | 1.30 | Protein levels | Hepatocyte | 134 | 1 | 5 | 9 | |
| 1556 | Medication, insulin therapy | METBL000027 | 1.29 | Metabolic | Hematopoietic progenitor | 22 | 1 | 5 | 11 | |
| 1557 | AHSP/HMBS ratio | PRORT000058 | 1.29 | Protein ratios | Lymphocyte | 33 | 4 | 16 | 48 | |
| 1558 | Gut microbial abundance, CAG-177 | GASTR000020 | 1.29 | Gastrointestinal | Salivary epithelium | 0 | 0 | 7 | 5 | |
| 1559 | PRKRA levels | PROLV001634 | 1.28 | Protein levels | Myeloid | 4 | 4 | 8 | 23 | |
| 1560 | DOK2/PDLIM7 ratio | PRORT000940 | 1.27 | Protein ratios | Muscle / cardiac | 6 | 4 | 14 | 19 | |
| 1561 | SCGB1A1 levels | PROLV001786 | 1.27 | Protein levels | Respiratory epithelium | 54 | 0 | 2 | 7 | |
| 1562 | NMNAT1 levels | PROLV001411 | 1.27 | Protein levels | Lymphocyte | 18 | 1 | 10 | 26 | |
| 1563 | Creatinine | NEPHR000018 | 1.27 | Nephrourologic | Hepatocyte | 2,903 | 2 | 6 | 8 | |
| 1564 | DAB2/ZBTB16 ratio | PRORT000843 | 1.27 | Protein ratios | Muscle / cardiac | 11 | 4 | 8 | 17 | |
| 1565 | RTBDN levels | PROLV001760 | 1.26 | Protein levels | B / plasma cell | 12 | 1 | 6 | 12 | |
| 1566 | ROR1 levels | PROLV001751 | 1.26 | Protein levels | Hepatocyte | 77 | 1 | 4 | 10 | |
| 1567 | CCL19 levels | PROLV000285 | 1.26 | Protein levels | Lymphocyte | 61 | 1 | 10 | 16 | |
| 1568 | Chronic kidney disease | NEPHR000001 | 1.25 | Nephrourologic | Hepatocyte | 63 | 1 | 4 | 8 | |
| 1569 | Urolithiasis | NEPHR000026 | 1.25 | Nephrourologic | Epithelial | 279 | 1 | 6 | 12 | |
| 1570 | NOTCH1 levels | PROLV001416 | 1.25 | Protein levels | Hepatocyte | 100 | 2 | 7 | 17 | |
| 1571 | CEP85 levels | PROLV000403 | 1.24 | Protein levels | Lymphocyte | 9 | 2 | 11 | 30 | |
| 1572 | Glucose regulation disorder | METBL000038 | 1.24 | Metabolic | Lymphocyte | 36 | 2 | 5 | 17 | |
| 1573 | FABP1/RBP2 ratio | PRORT001096 | 1.24 | Protein ratios | Hepatocyte | 29 | 1 | 7 | 8 | |
| 1574 | ARL13B levels | PROLV000143 | 1.23 | Protein levels | Stromal / connective | 0 | 1 | 5 | 10 | |
| 1575 | Short-chain fatty acids | METAB000053 | 1.23 | Metabolites | Granulosa cell | 20 | 5 | 12 | 17 | |
| 1576 | ESAM/TGFB1 ratio | PRORT001067 | 1.23 | Protein ratios | Muscle / cardiac | 20 | 4 | 11 | 17 | |
| 1577 | Endocrine gland disorder | ENDOC000003 | 1.23 | Endocrine | Neural / glial | 0 | 3 | 5 | 13 | |
| 1578 | CLEC14A/PTPRS ratio | PRORT000628 | 1.23 | Protein ratios | Vascular | 0 | 0 | 4 | 8 | |
| 1579 | MATN3 levels | PROLV001278 | 1.23 | Protein levels | Hepatocyte | 62 | 2 | 6 | 6 | |
| 1580 | JAM2/TNFRSF19 ratio | PRORT001400 | 1.23 | Protein ratios | Hematopoietic progenitor | 14 | 2 | 2 | 8 | |
| 1581 | PCDHB15 levels | PROLV001509 | 1.23 | Protein levels | Vascular | 46 | 2 | 6 | 9 | |
| 1582 | MARCO levels | PROLV001274 | 1.23 | Protein levels | Myeloid | 67 | 2 | 7 | 11 | |
| 1583 | Fatty acids, eicosatrienoic acid | LIPID000021 | 1.22 | Lipids | Lymphocyte | 2 | 2 | 7 | 13 | |
| 1584 | Spermatocele | REPRO000014 | 1.22 | Reproductive | Epithelial | 8 | 0 | 5 | 12 | |
| 1585 | EGLN1/PSIP1 ratio | PRORT001005 | 1.22 | Protein ratios | Myeloid | 0 | 0 | 3 | 8 | |
| 1586 | GLOD4/MIF ratio | PRORT001219 | 1.22 | Protein ratios | Hepatocyte | 0 | 2 | 7 | 21 | |
| 1587 | MOG/RTBDN ratio | PRORT001552 | 1.22 | Protein ratios | Stromal / connective | 4 | 2 | 8 | 21 | |
| 1588 | Platelet | HEMAT000025 | 1.22 | Hematologic | Platelet | 3,416 | 3 | 7 | 10 | |
| 1589 | UBE2L6 levels | PROLV002133 | 1.21 | Protein levels | Stromal / connective | 2 | 3 | 9 | 31 | |
| 1590 | Latent factor, white cell | HEMAT000039 | 1.21 | Hematologic | Myeloid | 183 | 2 | 4 | 24 | |
| 1591 | FN1 levels | PROLV000819 | 1.21 | Protein levels | Myeloid | 76 | 5 | 15 | 27 | |
| 1592 | FBP1/GSTA1 ratio | PRORT001118 | 1.21 | Protein ratios | Myeloid | 51 | 2 | 9 | 17 | |
| 1593 | Sulcal opening distance | NIMAG000012 | 1.21 | Neuroimaging | Vascular | 11 | 5 | 9 | 18 | |
| 1594 | THBD levels | PROLV002025 | 1.21 | Protein levels | Vascular | 104 | 1 | 4 | 11 | |
| 1595 | Handedness | BEHAV000003 | 1.20 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 1596 | Family medical history, none | MISCL000010 | 1.20 | Miscellaneous | Vascular | 6 | 0 | 0 | 3 | |
| 1597 | XRCC4 levels | PROLV002200 | 1.20 | Protein levels | Myeloid | 0 | 4 | 9 | 17 | |
| 1598 | CCL11/CCL2 ratio | PRORT000335 | 1.20 | Protein ratios | Muscle / cardiac | 13 | 2 | 5 | 11 | |
| 1599 | PVALB levels | PROLV001686 | 1.20 | Protein levels | Hematopoietic progenitor | 16 | 3 | 3 | 9 | |
| 1600 | LILRB1 levels | PROLV001213 | 1.20 | Protein levels | B / plasma cell | 214 | 5 | 14 | 33 | |
| 1601 | A1BG levels | PROLV000001 | 1.20 | Protein levels | Hepatocyte | 32 | 1 | 7 | 9 | |
| 1602 | ENO3 levels | PROLV000707 | 1.19 | Protein levels | Muscle / cardiac | 33 | 4 | 18 | 37 | |
| 1603 | HGF/MMP8 ratio | PRORT001282 | 1.19 | Protein ratios | Hepatocyte | 3 | 3 | 11 | 19 | |
| 1604 | IRF2 levels | PROLV001099 | 1.19 | Protein levels | Hepatocyte | 0 | 2 | 5 | 19 | |
| 1605 | METAP2 levels | PROLV001304 | 1.19 | Protein levels | Stromal / connective | 8 | 5 | 13 | 36 | |
| 1606 | CEACAM8/PGLYRP1 ratio | PRORT000588 | 1.19 | Protein ratios | Myeloid | 52 | 3 | 13 | 20 | |
| 1607 | PTPN1/SCAMP3 ratio | PRORT001716 | 1.19 | Protein ratios | Vascular | 11 | 3 | 9 | 14 | |
| 1608 | Bilirubin | HPBIL000017 | 1.19 | Hepatopancreatobiliary | Hepatocyte | 448 | 2 | 7 | 17 | |
| 1609 | GGT1/IL1RL2 ratio | PRORT001213 | 1.19 | Protein ratios | Hepatocyte | 23 | 2 | 11 | 16 | |
| 1610 | APRT levels | PROLV000131 | 1.19 | Protein levels | Lymphocyte | 4 | 3 | 7 | 36 | |
| 1611 | Triglycerides, HDL | LIPID000033 | 1.18 | Lipids | Hepatocyte | 1,558 | 3 | 8 | 16 | |
| 1612 | BAIAP2 levels | PROLV000176 | 1.18 | Protein levels | Myeloid | 12 | 2 | 10 | 11 | |
| 1613 | Medication, antithrombotic | VASCU000033 | 1.18 | Vascular | Vascular | 37 | 4 | 10 | 12 | |
| 1614 | MAVS/SCAMP3 ratio | PRORT001500 | 1.18 | Protein ratios | Neural / glial | 0 | 1 | 6 | 22 | |
| 1615 | TBCC levels | PROLV002000 | 1.18 | Protein levels | Myeloid | 7 | 4 | 8 | 11 | |
| 1616 | Free androgen index | ENDOC000007 | 1.18 | Endocrine | Hepatocyte | 616 | 1 | 6 | 20 | |
| 1617 | Prostate-specific antigen | REPRO000041 | 1.18 | Reproductive | Salivary epithelium | 56 | 1 | 7 | 8 | |
| 1618 | DLL1/IL18BP ratio | PRORT000915 | 1.18 | Protein ratios | Myeloid | 2 | 2 | 9 | 15 | |
| 1619 | SH2D1A levels | PROLV001852 | 1.17 | Protein levels | Lymphocyte | 41 | 2 | 10 | 28 | |
| 1620 | PM20D1 levels | PROLV001588 | 1.17 | Protein levels | Granulosa cell | 34 | 2 | 10 | 19 | |
| 1621 | EDAR/PSRC1 ratio | PRORT000975 | 1.17 | Protein ratios | Platelet | 0 | 6 | 9 | 20 | |
| 1622 | DPP6/SEZ6L ratio | PRORT000947 | 1.17 | Protein ratios | Adipose | 8 | 3 | 10 | 14 | |
| 1623 | TGFBR2/THBD ratio | PRORT001833 | 1.17 | Protein ratios | Vascular | 24 | 1 | 5 | 23 | |
| 1624 | ECM1 levels | PROLV000672 | 1.17 | Protein levels | Muscle / cardiac | 18 | 4 | 13 | 49 | |
| 1625 | PDGFA/SPARC ratio | PRORT001637 | 1.17 | Protein ratios | Hematopoietic progenitor | 6 | 3 | 6 | 15 | |
| 1626 | CHGA levels | PROLV000426 | 1.17 | Protein levels | Neural / glial | 33 | 2 | 5 | 12 | |
| 1627 | APOB/APOA1 ratio | PRORT000117 | 1.16 | Protein ratios | Hepatocyte | 343 | 1 | 9 | 14 | |
| 1628 | EDAR/IRAK4 ratio | PRORT000971 | 1.16 | Protein ratios | Myeloid | 38 | 2 | 13 | 16 | |
| 1629 | NFU1 levels | PROLV001400 | 1.16 | Protein levels | Stromal / connective | 2 | 3 | 7 | 16 | |
| 1630 | KLK14 levels | PROLV001154 | 1.16 | Protein levels | Neural / glial | 28 | 1 | 10 | 8 | |
| 1631 | CLEC1B/DKK1 ratio | PRORT000635 | 1.16 | Protein ratios | Lymphocyte | 1 | 3 | 13 | 30 | |
| 1632 | Gout | METBL000043 | 1.16 | Metabolic | Hepatocyte | 506 | 1 | 10 | 10 | |
| 1633 | CHMP1A/RHOC ratio | PRORT000613 | 1.16 | Protein ratios | Myeloid | 18 | 3 | 13 | 19 | |
| 1634 | LAYN/ULBP2 ratio | PRORT001435 | 1.15 | Protein ratios | Neural / glial | 3 | 1 | 8 | 13 | |
| 1635 | Mood symptoms | PSYCH000029 | 1.15 | Psychiatric | Neural / glial | 41 | 3 | 7 | 10 | |
| 1636 | APP/CCL28 ratio | PRORT000121 | 1.15 | Protein ratios | Granulosa cell | 8 | 6 | 8 | 20 | |
| 1637 | DAG1 levels | PROLV000592 | 1.14 | Protein levels | Lymphocyte | 4 | 4 | 10 | 23 | |
| 1638 | GAL/PM20D1 ratio | PRORT001200 | 1.14 | Protein ratios | Vascular | 23 | 3 | 14 | 18 | |
| 1639 | Intrahepatic cholestasis of pregnancy, ICP | HPBIL000001 | 1.14 | Hepatopancreatobiliary | Hepatocyte | 97 | 1 | 6 | 8 | |
| 1640 | TOP1 levels | PROLV002087 | 1.14 | Protein levels | Hepatocyte | 36 | 3 | 12 | 18 | |
| 1641 | ITGB1BP2 levels | PROLV001112 | 1.14 | Protein levels | Myeloid | 18 | 1 | 2 | 8 | |
| 1642 | CRKL/FIS1 ratio | PRORT000763 | 1.14 | Protein ratios | Hepatocyte | 1 | 1 | 12 | 15 | |
| 1643 | ENO2/ITGB1BP2 ratio | PRORT001024 | 1.14 | Protein ratios | Hematopoietic progenitor | 3 | 4 | 8 | 13 | |
| 1644 | RGMA levels | PROLV001728 | 1.14 | Protein levels | Muscle / cardiac | 126 | 1 | 7 | 11 | |
| 1645 | Brain age gap | NIMAG000004 | 1.13 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 1646 | Fatty acids, docosahexaenoic acid | LIPID000020 | 1.13 | Lipids | Hepatocyte | 789 | 4 | 9 | 16 | |
| 1647 | Diabetes, type 1 | IMMUN000012 | 1.13 | Immunologic | Lymphocyte | 291 | 2 | 14 | 6 | |
| 1648 | PAK4 levels | PROLV001488 | 1.13 | Protein levels | Myeloid | 1 | 3 | 8 | 16 | |
| 1649 | NCS1/NPY ratio | PRORT001576 | 1.12 | Protein ratios | Hepatocyte | 58 | 2 | 7 | 15 | |
| 1650 | EIF4EBP1 levels | PROLV000697 | 1.12 | Protein levels | Muscle / cardiac | 5 | 3 | 9 | 20 | |
| 1651 | CLPS levels | PROLV000463 | 1.12 | Protein levels | Vascular | 68 | 1 | 3 | 10 | |
| 1652 | TJAP1 levels | PROLV002043 | 1.11 | Protein levels | Stromal / connective | 1 | 2 | 5 | 14 | |
| 1653 | Cough | RESPI000027 | 1.11 | Respiratory | Myeloid | 0 | 4 | 7 | 11 | |
| 1654 | CD1C/CD207 ratio | PRORT000391 | 1.11 | Protein ratios | Myeloid | 46 | 3 | 9 | 13 | |
| 1655 | STK24/TDRKH ratio | PRORT001820 | 1.11 | Protein ratios | Myeloid | 0 | 4 | 15 | 39 | |
| 1656 | ARHGEF5 levels | PROLV000142 | 1.11 | Protein levels | Lymphocyte | 8 | 0 | 3 | 13 | |
| 1657 | DAB2/FKBP5 ratio | PRORT000837 | 1.10 | Protein ratios | Hepatocyte | 22 | 5 | 12 | 16 | |
| 1658 | AMOT levels | PROLV000087 | 1.10 | Protein levels | Hepatocyte | 22 | 1 | 5 | 15 | |
| 1659 | COL15A1 levels | PROLV000483 | 1.10 | Protein levels | Stromal / connective | 4 | 0 | 6 | 11 | |
| 1660 | Erythrocyte | HEMAT000005 | 1.10 | Hematologic | Hematopoietic progenitor | 3,061 | 3 | 7 | 17 | |
| 1661 | OCLN levels | PROLV001461 | 1.09 | Protein levels | Lymphocyte | 0 | 3 | 6 | 39 | |
| 1662 | Amyotrophic lateral sclerosis, ALS | NEURO000017 | 1.09 | Neurologic | Myeloid | 13 | 1 | 4 | 7 | |
| 1663 | DFFA levels | PROLV000615 | 1.09 | Protein levels | Stromal / connective | 1 | 3 | 10 | 13 | |
| 1664 | Sputum production | RESPI000033 | 1.09 | Respiratory | Myeloid | 0 | 4 | 9 | 14 | |
| 1665 | IL6ST levels | PROLV001079 | 1.09 | Protein levels | Hepatocyte | 62 | 2 | 7 | 15 | |
| 1666 | ADAM9 levels | PROLV000030 | 1.08 | Protein levels | Myeloid | 119 | 3 | 12 | 18 | |
| 1667 | CPM/LAMP2 ratio | PRORT000730 | 1.08 | Protein ratios | Hepatocyte | 42 | 2 | 11 | 22 | |
| 1668 | NFKBIE levels | PROLV001399 | 1.08 | Protein levels | Myeloid | 3 | 2 | 8 | 14 | |
| 1669 | EDAR/LAT2 ratio | PRORT000973 | 1.08 | Protein ratios | Myeloid | 1 | 5 | 15 | 23 | |
| 1670 | MAN2B2 levels | PROLV001261 | 1.08 | Protein levels | Hepatocyte | 53 | 4 | 17 | 35 | |
| 1671 | TNFRSF10A levels | PROLV002057 | 1.08 | Protein levels | Myeloid | 46 | 1 | 7 | 5 | |
| 1672 | SIGLEC7 levels | PROLV001863 | 1.08 | Protein levels | Myeloid | 20 | 1 | 13 | 11 | |
| 1673 | FKBP7 levels | PROLV000811 | 1.07 | Protein levels | Myeloid | 1 | 4 | 12 | 28 | |
| 1674 | ALCAM levels | PROLV000078 | 1.07 | Protein levels | Hepatocyte | 193 | 3 | 13 | 31 | |
| 1675 | NRSN1 levels | PROLV001436 | 1.07 | Protein levels | Lymphocyte | 0 | 2 | 14 | 32 | |
| 1676 | CNTN5/ROBO2 ratio | PRORT000688 | 1.06 | Protein ratios | Myeloid | 1 | 4 | 12 | 19 | |
| 1677 | MPHOSPH8/USP8 ratio | PRORT001555 | 1.06 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 44 | |
| 1678 | Brain general volume | NIMAG000015 | 1.06 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 1679 | Bile acid levels | HPBIL000016 | 1.06 | Hepatopancreatobiliary | Hepatocyte | 12 | 1 | 5 | 10 | |
| 1680 | APPL2 levels | PROLV000130 | 1.06 | Protein levels | Stromal / connective | 3 | 2 | 5 | 8 | |
| 1681 | Fatty acids ratio | LIPID000031 | 1.06 | Lipids | Hepatocyte | 426 | 2 | 8 | 18 | |
| 1682 | MAP2K6 levels | PROLV001267 | 1.06 | Protein levels | Muscle / cardiac | 13 | 5 | 13 | 22 | |
| 1683 | ADAMTSL4 levels | PROLV000037 | 1.06 | Protein levels | Myeloid | 49 | 3 | 12 | 24 | |
| 1684 | DNER levels | PROLV000637 | 1.06 | Protein levels | Vascular | 69 | 1 | 6 | 18 | |
| 1685 | Social support | SOCIO000022 | 1.05 | Socioeconomic | Neural / glial | 21 | 5 | 9 | 15 | |
| 1686 | CRH levels | PROLV000520 | 1.05 | Protein levels | Hematopoietic progenitor | 35 | 1 | 1 | 7 | |
| 1687 | PLTP levels | PROLV001582 | 1.05 | Protein levels | Myeloid | 143 | 4 | 14 | 17 | |
| 1688 | OBP2B levels | PROLV001460 | 1.05 | Protein levels | Respiratory epithelium | 12 | 0 | 8 | 9 | |
| 1689 | Nummular dermatitis | DERMA000014 | 1.05 | Dermatologic | Vascular | 0 | 0 | 2 | 5 | |
| 1690 | Sweets preference | DTSUP000019 | 1.05 | Diet and Supplement | Neural / glial | 88 | 4 | 7 | 13 | |
| 1691 | Pain, multi-site | MSKEL000038 | 1.05 | Musculoskeletal | Neural / glial | 13 | 5 | 10 | 28 | |
| 1692 | PDGFB/SPARC ratio | PRORT001645 | 1.04 | Protein ratios | Granulosa cell | 9 | 4 | 11 | 31 | |
| 1693 | FKBP1B/PRDX5 ratio | PRORT001151 | 1.04 | Protein ratios | Lymphocyte | 0 | 2 | 12 | 31 | |
| 1694 | ACE2 levels | PROLV000011 | 1.04 | Protein levels | Hepatocyte | 128 | 2 | 10 | 17 | |
| 1695 | TNFRSF11B levels | PROLV002061 | 1.04 | Protein levels | Hepatocyte | 94 | 1 | 6 | 16 | |
| 1696 | F10 levels | PROLV000740 | 1.03 | Protein levels | Hepatocyte | 80 | 3 | 10 | 14 | |
| 1697 | GDNF levels | PROLV000872 | 1.03 | Protein levels | Muscle / cardiac | 3 | 3 | 3 | 13 | |
| 1698 | FGF2 levels | PROLV000794 | 1.03 | Protein levels | Adipose | 20 | 2 | 4 | 16 | |
| 1699 | SCGB3A1 levels | PROLV001787 | 1.03 | Protein levels | Respiratory epithelium | 31 | 0 | 5 | 12 | |
| 1700 | SERPIND1 levels | PROLV001829 | 1.02 | Protein levels | Hepatocyte | 143 | 3 | 10 | 11 | |
| 1701 | Diabetes, gestational | METBL000031 | 1.02 | Metabolic | Hepatocyte | 48 | 1 | 5 | 5 | |
| 1702 | PEAR1 levels | PROLV001532 | 1.02 | Protein levels | Myeloid | 16 | 1 | 8 | 12 | |
| 1703 | CEP43/WASF1 ratio | PRORT000603 | 1.02 | Protein ratios | Myeloid | 0 | 1 | 7 | 11 | |
| 1704 | CD200 levels | PROLV000316 | 1.02 | Protein levels | Adipose | 41 | 1 | 7 | 7 | |
| 1705 | CD300C/NBL1 ratio | PRORT000428 | 1.01 | Protein ratios | Myeloid | 19 | 2 | 10 | 16 | |
| 1706 | EGFR levels | PROLV000687 | 1.01 | Protein levels | Adipose | 22 | 3 | 10 | 13 | |
| 1707 | RRM2B levels | PROLV001757 | 1.01 | Protein levels | Myeloid | 1 | 3 | 8 | 10 | |
| 1708 | SPINK5/SPINT1 ratio | PRORT001809 | 1.01 | Protein ratios | Gastrointestinal epithelium | 11 | 0 | 10 | 4 | |
| 1709 | Anaemia | HEMAT000001 | 1.01 | Hematologic | Myeloid | 22 | 1 | 6 | 5 | |
| 1710 | MAVS levels | PROLV001279 | 1.00 | Protein levels | Myeloid | 7 | 3 | 3 | 11 | |
| 1711 | Medication, antiglaucoma | OPHTH000014 | 1.00 | Ophthalmic | Stromal / connective | 69 | 2 | 5 | 12 | |
| 1712 | LRRC25 levels | PROLV001232 | 1.00 | Protein levels | Myeloid | 135 | 2 | 9 | 10 | |
| 1713 | AZU1/CEACAM8 ratio | PRORT000184 | 1.00 | Protein ratios | Myeloid | 24 | 2 | 5 | 14 | |
| 1714 | IGFBP7 levels | PROLV001033 | 0.99 | Protein levels | Hepatocyte | 24 | 1 | 7 | 17 | |
| 1715 | AXIN1/INPPL1 ratio | PRORT000172 | 0.99 | Protein ratios | Granulosa cell | 1 | 3 | 9 | 11 | |
| 1716 | LGALS1 levels | PROLV001201 | 0.99 | Protein levels | Vascular | 9 | 2 | 4 | 16 | |
| 1717 | KHK levels | PROLV001135 | 0.99 | Protein levels | Hepatocyte | 45 | 3 | 16 | 39 | |
| 1718 | Gestational age at birth | REPRO000040 | 0.99 | Reproductive | Neural / glial | 0 | 1 | 7 | 10 | |
| 1719 | PTPRC levels | PROLV001674 | 0.99 | Protein levels | Lymphocyte | 55 | 2 | 13 | 35 | |
| 1720 | TNFRSF13B/TNFRSF13C ratio | PRORT001846 | 0.99 | Protein ratios | B / plasma cell | 23 | 4 | 9 | 15 | |
| 1721 | CD27/ICAM3 ratio | PRORT000414 | 0.98 | Protein ratios | B / plasma cell | 33 | 0 | 4 | 7 | |
| 1722 | Housing tenure | SOCIO000012 | 0.98 | Socioeconomic | Neural / glial | 0 | 5 | 9 | 20 | |
| 1723 | MARS1 levels | PROLV001275 | 0.98 | Protein levels | Stromal / connective | 0 | 3 | 6 | 20 | |
| 1724 | DKK1/SERPINE1 ratio | PRORT000902 | 0.98 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 8 | 18 | |
| 1725 | PCOLCE levels | PROLV001510 | 0.98 | Protein levels | Neural / glial | 1 | 2 | 6 | 14 | |
| 1726 | ICAM1/REG1A ratio | PRORT001322 | 0.97 | Protein ratios | Myeloid | 16 | 3 | 9 | 17 | |
| 1727 | UNC5D levels | PROLV002141 | 0.97 | Protein levels | Neural / glial | 0 | 1 | 7 | 30 | |
| 1728 | CX3CL1 levels | PROLV000573 | 0.97 | Protein levels | Vascular | 67 | 2 | 4 | 14 | |
| 1729 | STK11 levels | PROLV001963 | 0.97 | Protein levels | Vascular | 37 | 2 | 7 | 12 | |
| 1730 | Glycerophosphocholines | LIPID000053 | 0.96 | Lipids | Neural / glial | 0 | 2 | 11 | 17 | |
| 1731 | Ocular alignment disorder | OPHTH000023 | 0.96 | Ophthalmic | Myeloid | 9 | 4 | 9 | 17 | |
| 1732 | Movement disorder | NEURO000015 | 0.96 | Neurologic | Neural / glial | 43 | 2 | 7 | 11 | |
| 1733 | CXCL17/SFTPA2 ratio | PRORT000824 | 0.96 | Protein ratios | Myeloid | 3 | 2 | 8 | 18 | |
| 1734 | IGDCC4 levels | PROLV001024 | 0.96 | Protein levels | Myeloid | 46 | 4 | 11 | 16 | |
| 1735 | Pyrimidine metabolites | METAB000063 | 0.95 | Metabolites | Granulosa cell | 0 | 1 | 7 | 16 | |
| 1736 | Biliary cirrhosis | HPBIL000005 | 0.95 | Hepatopancreatobiliary | Salivary epithelium | — | 0 | 12 | 10 | |
| 1737 | TST levels | PROLV002117 | 0.95 | Protein levels | Neural / glial | 2 | 2 | 5 | 15 | |
| 1738 | GLT25D1 levels | PROLV000899 | 0.95 | Protein levels | Vascular | 0 | 1 | 4 | 5 | |
| 1739 | Dermatophytosis | IMMUN000059 | 0.95 | Immunologic | Myeloid | 30 | 2 | 7 | 10 | |
| 1740 | Mood disorder | PSYCH000028 | 0.94 | Psychiatric | Neural / glial | 8 | 5 | 10 | 11 | |
| 1741 | Pregnancy complication, ectopic | REPRO000028 | 0.94 | Reproductive | Vascular | 1 | 1 | 11 | 28 | |
| 1742 | SIGLEC5 levels | PROLV001861 | 0.94 | Protein levels | Myeloid | 33 | 2 | 6 | 9 | |
| 1743 | VMO1 levels | PROLV002163 | 0.93 | Protein levels | Myeloid | 67 | 4 | 12 | 14 | |
| 1744 | Tyrosine metabolites | METAB000016 | 0.93 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 1745 | Amino acid metabolites | METAB000002 | 0.93 | Metabolites | Neural / glial | 0 | 0 | 7 | 11 | |
| 1746 | IRAK4/VASH1 ratio | PRORT001370 | 0.93 | Protein ratios | Muscle / cardiac | 0 | 2 | 5 | 16 | |
| 1747 | CXCL5/MESD ratio | PRORT000828 | 0.93 | Protein ratios | Lymphocyte | 2 | 3 | 11 | 25 | |
| 1748 | ACP5 levels | PROLV000014 | 0.93 | Protein levels | Myeloid | 150 | 2 | 11 | 22 | |
| 1749 | CALCOCO2 levels | PROLV000258 | 0.93 | Protein levels | Vascular | 11 | 4 | 5 | 16 | |
| 1750 | ERBB2/GUSB ratio | PRORT001043 | 0.92 | Protein ratios | Hepatocyte | 25 | 3 | 13 | 29 | |
| 1751 | CNDP1 levels | PROLV000471 | 0.92 | Protein levels | Hepatocyte | 75 | 2 | 12 | 12 | |
| 1752 | ACVRL1/EFNA4 ratio | PRORT000014 | 0.92 | Protein ratios | Vascular | 35 | 4 | 10 | 14 | |
| 1753 | Cancer, Prostate | MALIG000026 | 0.92 | Malignancy | Gastrointestinal epithelium | 330 | 1 | 7 | 10 | |
| 1754 | ARF6 levels | PROLV000133 | 0.92 | Protein levels | Stromal / connective | 50 | 5 | 15 | 21 | |
| 1755 | TRIM40 levels | PROLV002109 | 0.92 | Protein levels | Muscle / cardiac | 52 | 4 | 10 | 9 | |
| 1756 | APEX1/LSP1 ratio | PRORT000116 | 0.92 | Protein ratios | Myeloid | 14 | 4 | 9 | 14 | |
| 1757 | BCAM/CDH5 ratio | PRORT000206 | 0.91 | Protein ratios | Vascular | 42 | 1 | 12 | 12 | |
| 1758 | VSIG2 levels | PROLV002170 | 0.91 | Protein levels | Renal epithelium | 16 | 0 | 8 | 3 | |
| 1759 | CST3/TFF3 ratio | PRORT000788 | 0.90 | Protein ratios | Adipose | 7 | 1 | 9 | 12 | |
| 1760 | SEZ6L levels | PROLV001841 | 0.90 | Protein levels | Myeloid | 76 | 2 | 8 | 7 | |
| 1761 | Carpal tunnel surgery | MSKEL000044 | 0.90 | Musculoskeletal | Stromal / connective | 5 | 4 | 6 | 11 | |
| 1762 | TRIM21 levels | PROLV002106 | 0.90 | Protein levels | Stromal / connective | 22 | 1 | 6 | 17 | |
| 1763 | SEMA4D levels | PROLV001810 | 0.90 | Protein levels | Lymphocyte | 3 | 4 | 9 | 24 | |
| 1764 | LTBP2/MYOC ratio | PRORT001464 | 0.89 | Protein ratios | Neural / glial | 0 | 3 | 8 | 16 | |
| 1765 | Frailty, limited social support | SOCIO000017 | 0.89 | Socioeconomic | Neural / glial | 0 | 4 | 4 | 9 | |
| 1766 | CKMB levels | PROLV000441 | 0.89 | Protein levels | Muscle / cardiac | 9 | 3 | 10 | 26 | |
| 1767 | CRTAC1 levels | PROLV000529 | 0.89 | Protein levels | Myeloid | 136 | 2 | 12 | 16 | |
| 1768 | TYRO3 levels | PROLV002129 | 0.88 | Protein levels | Lymphocyte | 36 | 1 | 9 | 30 | |
| 1769 | FSTL3 levels | PROLV000831 | 0.88 | Protein levels | Neural / glial | 17 | 2 | 3 | 8 | |
| 1770 | CPB1/CTRB1 ratio | PRORT000724 | 0.88 | Protein ratios | Epithelial | 26 | 0 | 9 | 14 | |
| 1771 | TNFRSF10C levels | PROLV002059 | 0.88 | Protein levels | Myeloid | 116 | 1 | 5 | 7 | |
| 1772 | Chondrocalcinosis | MSKEL000014 | 0.88 | Musculoskeletal | Vascular | 0 | 1 | 6 | 12 | |
| 1773 | BMP7 levels | PROLV000205 | 0.88 | Protein levels | Lymphocyte | 0 | 2 | 14 | 29 | |
| 1774 | LYN levels | PROLV001251 | 0.88 | Protein levels | Myeloid | 41 | 2 | 7 | 13 | |
| 1775 | RAB2B levels | PROLV001698 | 0.88 | Protein levels | Stromal / connective | 1 | 3 | 4 | 9 | |
| 1776 | PDLIM5 levels | PROLV001528 | 0.88 | Protein levels | Stromal / connective | 1 | 3 | 13 | 30 | |
| 1777 | Bicarbonate | METAB000042 | 0.88 | Metabolites | Renal epithelium | 656 | 1 | 6 | 6 | |
| 1778 | Nasal septum deviation | RESPI000038 | 0.88 | Respiratory | Epithelial | 1 | 2 | 14 | 15 | |
| 1779 | NRCAM levels | PROLV001432 | 0.87 | Protein levels | Myeloid | 88 | 3 | 9 | 10 | |
| 1780 | Circadian timing | BEHAV000014 | 0.87 | Behavioural | Neural / glial | 79 | 2 | 9 | 16 | |
| 1781 | Hydrocele | REPRO000012 | 0.87 | Reproductive | Stromal / connective | 7 | 0 | 8 | 15 | |
| 1782 | SCGN levels | PROLV001789 | 0.87 | Protein levels | Gastrointestinal epithelium | 12 | 0 | 6 | 12 | |
| 1783 | Enthesopathy | MSKEL000061 | 0.87 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 1784 | EPHA4 levels | PROLV000718 | 0.87 | Protein levels | Granulosa cell | 35 | 1 | 8 | 20 | |
| 1785 | Psychiatric disorder | PSYCH000016 | 0.87 | Psychiatric | Neural / glial | 0 | 2 | 7 | 11 | |
| 1786 | LTB4R levels | PROLV001241 | 0.87 | Protein levels | Myeloid | 8 | 3 | 12 | 18 | |
| 1787 | LTA levels | PROLV001239 | 0.87 | Protein levels | Lymphocyte | 112 | 3 | 17 | 32 | |
| 1788 | DBI/EDAR ratio | PRORT000861 | 0.86 | Protein ratios | Myeloid | 37 | 3 | 6 | 16 | |
| 1789 | ITGB1 levels | PROLV001111 | 0.86 | Protein levels | Myeloid | 78 | 4 | 10 | 28 | |
| 1790 | Adhesive capsulitis | MSKEL000058 | 0.86 | Musculoskeletal | Stromal / connective | 26 | 1 | 5 | 13 | |
| 1791 | ALCAM/NOTCH1 ratio | PRORT000075 | 0.86 | Protein ratios | Myeloid | 36 | 2 | 14 | 20 | |
| 1792 | FABP2/LGALS4 ratio | PRORT001098 | 0.86 | Protein ratios | Hepatocyte | 25 | 1 | 9 | 13 | |
| 1793 | EFNA4 levels | PROLV000682 | 0.86 | Protein levels | Lymphocyte | 16 | 1 | 9 | 21 | |
| 1794 | Subarachnoid haemorrhage | VASCU000018 | 0.85 | Vascular | Granulosa cell | 0 | 0 | 5 | 6 | |
| 1795 | RHOC/TBCC ratio | PRORT001741 | 0.85 | Protein ratios | Myeloid | 0 | 4 | 10 | 12 | |
| 1796 | GLA levels | PROLV000893 | 0.85 | Protein levels | Lymphocyte | 2 | 3 | 6 | 30 | |
| 1797 | HYOU1/PTPRF ratio | PRORT001314 | 0.85 | Protein ratios | Hepatocyte | 56 | 1 | 8 | 8 | |
| 1798 | MSRA/P4HB ratio | PRORT001561 | 0.85 | Protein ratios | Neural / glial | 24 | 6 | 15 | 25 | |
| 1799 | PMVK levels | PROLV001590 | 0.85 | Protein levels | Myeloid | 34 | 3 | 8 | 12 | |
| 1800 | EBAG9/MITD1 ratio | PRORT000960 | 0.85 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 18 | |
| 1801 | Hydrocephalus | NEURO000002 | 0.84 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 1802 | PTPRH levels | PROLV001676 | 0.84 | Protein levels | Vascular | 69 | 3 | 7 | 15 | |
| 1803 | BLVRB/CA1 ratio | PRORT000238 | 0.84 | Protein ratios | Myeloid | 1 | 2 | 5 | 11 | |
| 1804 | LTA4H levels | PROLV001240 | 0.84 | Protein levels | Muscle / cardiac | 0 | 3 | 16 | 38 | |
| 1805 | Deafness with mutism | AUDIO000010 | 0.84 | Auditory | Hepatocyte | 0 | 1 | 9 | 18 | |
| 1806 | CGREF1/FAM3C ratio | PRORT000609 | 0.83 | Protein ratios | Hepatocyte | 2 | 0 | 4 | 8 | |
| 1807 | KLKB1 levels | PROLV001160 | 0.83 | Protein levels | Hepatocyte | 103 | 2 | 7 | 17 | |
| 1808 | Cancer, Testis | MALIG000031 | 0.83 | Malignancy | B / plasma cell | 0 | 0 | 1 | 7 | |
| 1809 | TANK levels | PROLV001992 | 0.83 | Protein levels | Stromal / connective | 1 | 5 | 12 | 33 | |
| 1810 | DSG3/FABP9 ratio | PRORT000953 | 0.83 | Protein ratios | Cutaneous epithelium | 2 | 0 | 4 | 6 | |
| 1811 | Iron content, Spleen | METBL000018 | 0.83 | Metabolic | Myeloid | 10 | 2 | 5 | 10 | |
| 1812 | LAT/PLXNA4 ratio | PRORT001425 | 0.83 | Protein ratios | Myeloid | 18 | 3 | 12 | 26 | |
| 1813 | Ornithine metabolites | METAB000011 | 0.83 | Metabolites | B / plasma cell | 0 | 2 | 9 | 9 | |
| 1814 | CLIP2/LAT2 ratio | PRORT000666 | 0.83 | Protein ratios | Epithelial | 1 | 2 | 10 | 11 | |
| 1815 | FST/FSTL3 ratio | PRORT001180 | 0.83 | Protein ratios | Stromal / connective | 0 | 4 | 15 | 20 | |
| 1816 | SMPD1 levels | PROLV001901 | 0.83 | Protein levels | Hepatocyte | 179 | 1 | 7 | 16 | |
| 1817 | SERPINI2 levels | PROLV001837 | 0.83 | Protein levels | Pancreatic epithelium | 137 | 0 | 2 | 3 | |
| 1818 | AXIN1/IKBKG ratio | PRORT000171 | 0.83 | Protein ratios | Muscle / cardiac | 10 | 5 | 13 | 29 | |
| 1819 | GDI2 levels | PROLV000871 | 0.82 | Protein levels | Hepatocyte | 0 | 4 | 12 | 35 | |
| 1820 | DNAJA2/HPCAL1 ratio | PRORT000922 | 0.82 | Protein ratios | Myeloid | 2 | 5 | 16 | 37 | |
| 1821 | LAMA4/NID1 ratio | PRORT001419 | 0.82 | Protein ratios | Vascular | 14 | 5 | 12 | 24 | |
| 1822 | GRP levels | PROLV000934 | 0.82 | Protein levels | Granulosa cell | 6 | 2 | 3 | 7 | |
| 1823 | BLVRB/CA2 ratio | PRORT000239 | 0.82 | Protein ratios | Vascular | 0 | 0 | 7 | 11 | |
| 1824 | AXIN1/ITGB1BP2 ratio | PRORT000173 | 0.81 | Protein ratios | Myeloid | 19 | 5 | 16 | 18 | |
| 1825 | RAD23B levels | PROLV001703 | 0.81 | Protein levels | Stromal / connective | 1 | 4 | 9 | 14 | |
| 1826 | CPM levels | PROLV000507 | 0.81 | Protein levels | Myeloid | 138 | 3 | 11 | 11 | |
| 1827 | PIKFYVE levels | PROLV001559 | 0.81 | Protein levels | Lymphocyte | 3 | 2 | 11 | 31 | |
| 1828 | IRAK1 levels | PROLV001097 | 0.81 | Protein levels | Vascular | 10 | 3 | 10 | 15 | |
| 1829 | DCXR/GSTA1 ratio | PRORT000876 | 0.80 | Protein ratios | Neural / glial | 31 | 6 | 11 | 16 | |
| 1830 | CKAP4/LTBR ratio | PRORT000622 | 0.80 | Protein ratios | Muscle / cardiac | 17 | 1 | 6 | 18 | |
| 1831 | FABP9 levels | PROLV000757 | 0.80 | Protein levels | Cutaneous epithelium | 43 | 0 | 4 | 5 | |
| 1832 | EPHA2 levels | PROLV000717 | 0.80 | Protein levels | Epithelial | 41 | 0 | 4 | 2 | |
| 1833 | CD58/ERBB3 ratio | PRORT000472 | 0.80 | Protein ratios | Hepatocyte | 55 | 1 | 5 | 12 | |
| 1834 | PSG1 levels | PROLV001656 | 0.80 | Protein levels | Myeloid | 41 | 4 | 13 | 21 | |
| 1835 | SOST/SPP1 ratio | PRORT001805 | 0.80 | Protein ratios | Myeloid | 11 | 2 | 5 | 10 | |
| 1836 | ERBIN/SIRT2 ratio | PRORT001050 | 0.79 | Protein ratios | Hepatocyte | 21 | 2 | 8 | 12 | |
| 1837 | CRTAM/PDCD1 ratio | PRORT000773 | 0.79 | Protein ratios | Lymphocyte | 7 | 2 | 19 | 43 | |
| 1838 | OSCAR levels | PROLV001474 | 0.79 | Protein levels | Hematopoietic progenitor | 181 | 4 | 9 | 11 | |
| 1839 | BCAN/DPP6 ratio | PRORT000215 | 0.79 | Protein ratios | Stromal / connective | 0 | 5 | 11 | 20 | |
| 1840 | CA2/CA3 ratio | PRORT000274 | 0.79 | Protein ratios | Muscle / cardiac | 0 | 3 | 11 | 23 | |
| 1841 | LACRT levels | PROLV001173 | 0.79 | Protein levels | Cutaneous epithelium | 32 | 1 | 8 | 13 | |
| 1842 | CASP8/SEPTIN9 ratio | PRORT000325 | 0.79 | Protein ratios | Myeloid | 1 | 2 | 11 | 11 | |
| 1843 | EIF4G1/MAVS ratio | PRORT001011 | 0.79 | Protein ratios | Myeloid | 22 | 3 | 9 | 16 | |
| 1844 | Cancer, Breast | MALIG000011 | 0.79 | Malignancy | Cutaneous epithelium | 47 | 1 | 8 | 13 | |
| 1845 | FOLR2/HAVCR2 ratio | PRORT001168 | 0.79 | Protein ratios | Myeloid | 79 | 5 | 20 | 28 | |
| 1846 | Snack and fast-food preference | DTSUP000017 | 0.79 | Diet and Supplement | Neural / glial | 36 | 4 | 7 | 24 | |
| 1847 | PDGFRB levels | PROLV001526 | 0.79 | Protein levels | Myeloid | 59 | 6 | 15 | 28 | |
| 1848 | DUSP3 levels | PROLV000663 | 0.79 | Protein levels | Myeloid | 6 | 1 | 7 | 11 | |
| 1849 | DAPP1/PTPN6 ratio | PRORT000856 | 0.79 | Protein ratios | Hepatocyte | 0 | 1 | 7 | 10 | |
| 1850 | CDC37 levels | PROLV000368 | 0.78 | Protein levels | Platelet | 16 | 4 | 6 | 23 | |
| 1851 | Employment status | SOCIO000005 | 0.78 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 1852 | SLC51B levels | PROLV001883 | 0.78 | Protein levels | B / plasma cell | 4 | 0 | 6 | 9 | |
| 1853 | MANF/TXNDC5 ratio | PRORT001482 | 0.78 | Protein ratios | Hepatocyte | 1 | 5 | 12 | 22 | |
| 1854 | AKR1B1 levels | PROLV000072 | 0.78 | Protein levels | Stromal / connective | 11 | 7 | 10 | 27 | |
| 1855 | PTPN1 levels | PROLV001671 | 0.77 | Protein levels | Vascular | 7 | 4 | 7 | 22 | |
| 1856 | CLEC6A levels | PROLV000456 | 0.77 | Protein levels | Myeloid | 53 | 3 | 9 | 17 | |
| 1857 | Branched-chain amino acid metabolites | METAB000004 | 0.77 | Metabolites | Lymphocyte | 0 | 1 | 8 | 31 | |
| 1858 | PMM2 levels | PROLV001589 | 0.77 | Protein levels | Stromal / connective | 2 | 2 | 6 | 12 | |
| 1859 | Bone and cartilage disorder | MSKEL000006 | 0.77 | Musculoskeletal | Neural / glial | 1 | 0 | 0 | 4 | |
| 1860 | HNRNPK/USP8 ratio | PRORT001293 | 0.77 | Protein ratios | B / plasma cell | 0 | 2 | 9 | 18 | |
| 1861 | LCN2/RETN ratio | PRORT001443 | 0.77 | Protein ratios | Myeloid | 41 | 2 | 8 | 14 | |
| 1862 | AMOTL2 levels | PROLV000088 | 0.77 | Protein levels | Lymphocyte | 1 | 0 | 9 | 14 | |
| 1863 | MESD/NCK2 ratio | PRORT001516 | 0.77 | Protein ratios | Neural / glial | 8 | 4 | 10 | 17 | |
| 1864 | FAM3B/GPA33 ratio | PRORT001113 | 0.77 | Protein ratios | Vascular | 17 | 0 | 4 | 7 | |
| 1865 | SPOCK2 levels | PROLV001935 | 0.76 | Protein levels | Hepatocyte | 5 | 2 | 6 | 12 | |
| 1866 | COMP/MYOC ratio | PRORT000712 | 0.76 | Protein ratios | Adipose | 3 | 4 | 14 | 23 | |
| 1867 | Isoleucine | METAB000024 | 0.76 | Metabolites | Hepatocyte | 28 | 3 | 6 | 20 | |
| 1868 | OPTC levels | PROLV001472 | 0.76 | Protein levels | Stromal / connective | 11 | 2 | 7 | 11 | |
| 1869 | COL18A1/RARRES2 ratio | PRORT000691 | 0.76 | Protein ratios | Myeloid | 30 | 2 | 7 | 12 | |
| 1870 | Congenital cardiovascular malformations | CARDI000031 | 0.76 | Cardiac | Vascular | 0 | 4 | 10 | 28 | |
| 1871 | AZU1/MPO ratio | PRORT000185 | 0.76 | Protein ratios | Myeloid | 8 | 1 | 4 | 8 | |
| 1872 | Cancer, Bladder | MALIG000009 | 0.76 | Malignancy | Cutaneous epithelium | 3 | 0 | 11 | 8 | |
| 1873 | GBP6 levels | PROLV000863 | 0.76 | Protein levels | Hepatocyte | 11 | 2 | 9 | 14 | |
| 1874 | Telomere length | AGING000001 | 0.76 | Aging | Hematopoietic progenitor | 228 | 2 | 10 | 22 | |
| 1875 | LAT/LYN ratio | PRORT001422 | 0.76 | Protein ratios | Lymphocyte | 0 | 2 | 17 | 49 | |
| 1876 | SPINT1/SUSD2 ratio | PRORT001810 | 0.76 | Protein ratios | B / plasma cell | 20 | 1 | 6 | 7 | |
| 1877 | ADH4/KYNU ratio | PRORT000041 | 0.75 | Protein ratios | Hepatocyte | 41 | 4 | 16 | 28 | |
| 1878 | Benign neoplasm, Endocrine | MALIG000003 | 0.75 | Malignancy | Myeloid | 1 | 3 | 9 | 18 | |
| 1879 | RHOC levels | PROLV001732 | 0.75 | Protein levels | Myeloid | 31 | 2 | 6 | 15 | |
| 1880 | FLT4/KDR ratio | PRORT001167 | 0.75 | Protein ratios | Vascular | 28 | 1 | 7 | 21 | |
| 1881 | IGSF9 levels | PROLV001040 | 0.75 | Protein levels | Hepatocyte | 63 | 3 | 9 | 17 | |
| 1882 | BIRC2 levels | PROLV000198 | 0.75 | Protein levels | Stromal / connective | 1 | 3 | 7 | 14 | |
| 1883 | Cutaneous and subcutaneous lipoma | DERMA000001 | 0.75 | Dermatologic | Lymphocyte | 0 | 3 | 13 | 26 | |
| 1884 | TGFBR3 levels | PROLV002023 | 0.74 | Protein levels | Adipose | 33 | 3 | 6 | 14 | |
| 1885 | AGER levels | PROLV000054 | 0.74 | Protein levels | Vascular | 97 | 1 | 7 | 11 | |
| 1886 | FOLH1 levels | PROLV000821 | 0.74 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 1887 | SFTPA2/SFTPD ratio | PRORT001782 | 0.74 | Protein ratios | Epithelial | 11 | 1 | 4 | 4 | |
| 1888 | VSIG4 levels | PROLV002171 | 0.74 | Protein levels | Myeloid | 35 | 2 | 7 | 10 | |
| 1889 | ROBO2/SFTPD ratio | PRORT001746 | 0.74 | Protein ratios | Neural / glial | 15 | 1 | 5 | 19 | |
| 1890 | Alanine | METAB000017 | 0.74 | Metabolites | Hepatocyte | 251 | 1 | 5 | 12 | |
| 1891 | MCAM/NTRK3 ratio | PRORT001506 | 0.74 | Protein ratios | Vascular | 17 | 2 | 8 | 14 | |
| 1892 | Cholesterol, HDL | LIPID000003 | 0.74 | Lipids | Hepatocyte | 4,625 | 3 | 8 | 17 | |
| 1893 | Dizziness and giddiness | AUDIO000020 | 0.74 | Auditory | Neural / glial | 0 | 4 | 14 | 32 | |
| 1894 | Cardiac implants and grafts | CARDI000048 | 0.74 | Cardiac | Vascular | 36 | 4 | 9 | 23 | |
| 1895 | APOC1 levels | PROLV000122 | 0.74 | Protein levels | Myeloid | 58 | 2 | 13 | 19 | |
| 1896 | CLEC1B/EGF ratio | PRORT000636 | 0.73 | Protein ratios | Myeloid | 5 | 1 | 8 | 8 | |
| 1897 | DARS1/USP8 ratio | PRORT000860 | 0.73 | Protein ratios | Hepatocyte | 3 | 3 | 8 | 17 | |
| 1898 | DBN1 levels | PROLV000598 | 0.73 | Protein levels | Myeloid | 0 | 3 | 5 | 9 | |
| 1899 | ITIH4 levels | PROLV001119 | 0.73 | Protein levels | Hepatocyte | 94 | 2 | 8 | 17 | |
| 1900 | SRPX levels | PROLV001945 | 0.73 | Protein levels | Adipose | 32 | 4 | 10 | 16 | |
| 1901 | CSF volume | NIMAG000018 | 0.73 | Neuroimaging | Stromal / connective | 16 | 2 | 2 | 6 | |
| 1902 | MYL3 levels | PROLV001360 | 0.73 | Protein levels | Muscle / cardiac | 42 | 3 | 8 | 20 | |
| 1903 | TARBP2/TDRKH ratio | PRORT001826 | 0.73 | Protein ratios | Granulosa cell | 0 | 3 | 8 | 16 | |
| 1904 | TNR levels | PROLV002084 | 0.72 | Protein levels | Vascular | 90 | 3 | 8 | 15 | |
| 1905 | AXL/IL18BP ratio | PRORT000180 | 0.72 | Protein ratios | Neural / glial | 26 | 2 | 10 | 15 | |
| 1906 | KLK13 levels | PROLV001153 | 0.72 | Protein levels | Myeloid | 106 | 2 | 10 | 12 | |
| 1907 | DLL1/EFEMP1 ratio | PRORT000914 | 0.72 | Protein ratios | Hepatocyte | 33 | 2 | 7 | 20 | |
| 1908 | CSF unidentified metabolite | METAB000075 | 0.72 | Metabolites | Muscle / cardiac | 1 | 0 | 2 | 3 | |
| 1909 | PLA2G1B levels | PROLV001567 | 0.72 | Protein levels | Pancreatic epithelium | 69 | 0 | 4 | 6 | |
| 1910 | TNFAIP2 levels | PROLV002054 | 0.72 | Protein levels | Myeloid | 10 | 2 | 4 | 10 | |
| 1911 | Orbital disorder | OPHTH000021 | 0.72 | Ophthalmic | Lymphocyte | 47 | 3 | 15 | 38 | |
| 1912 | SH2B3/SUGT1 ratio | PRORT001783 | 0.72 | Protein ratios | Muscle / cardiac | 24 | 3 | 9 | 23 | |
| 1913 | CDCP1/MSR1 ratio | PRORT000544 | 0.72 | Protein ratios | Myeloid | 26 | 2 | 10 | 13 | |
| 1914 | Acne | DERMA000028 | 0.71 | Dermatologic | Cutaneous epithelium | 14 | 0 | 8 | 7 | |
| 1915 | GSR levels | PROLV000938 | 0.71 | Protein levels | Myeloid | 12 | 3 | 11 | 26 | |
| 1916 | C-reactive protein | HPBIL000026 | 0.71 | Hepatopancreatobiliary | Hepatocyte | 1,267 | 3 | 10 | 20 | |
| 1917 | CD300C/HAVCR2 ratio | PRORT000425 | 0.71 | Protein ratios | Myeloid | 48 | 3 | 11 | 16 | |
| 1918 | RARRES2/TFPI ratio | PRORT001728 | 0.71 | Protein ratios | Hepatocyte | 38 | 1 | 9 | 17 | |
| 1919 | HEPH levels | PROLV000963 | 0.71 | Protein levels | Lymphocyte | 12 | 0 | 9 | 27 | |
| 1920 | ITM2A levels | PROLV001120 | 0.71 | Protein levels | Hepatocyte | 32 | 3 | 11 | 28 | |
| 1921 | HYAL1 levels | PROLV001001 | 0.70 | Protein levels | Vascular | 33 | 3 | 10 | 14 | |
| 1922 | CD69/CDKN2D ratio | PRORT000487 | 0.70 | Protein ratios | Vascular | 6 | 3 | 8 | 16 | |
| 1923 | WFDC12 levels | PROLV002189 | 0.70 | Protein levels | Cutaneous epithelium | 113 | 1 | 7 | 9 | |
| 1924 | Frailty, multimorbidity | METBL000012 | 0.70 | Metabolic | Vascular | 188 | 3 | 10 | 10 | |
| 1925 | HAVCR1 levels | PROLV000953 | 0.70 | Protein levels | Hepatocyte | 20 | 0 | 8 | 27 | |
| 1926 | C5 levels | PROLV000235 | 0.70 | Protein levels | Hepatocyte | 10 | 4 | 15 | 40 | |
| 1927 | EDAR/TNFSF12 ratio | PRORT000982 | 0.70 | Protein ratios | Hematopoietic progenitor | 34 | 5 | 9 | 21 | |
| 1928 | BCAN/KLK6 ratio | PRORT000216 | 0.70 | Protein ratios | Myeloid | 11 | 2 | 7 | 12 | |
| 1929 | FGF5 levels | PROLV000797 | 0.70 | Protein levels | Hepatocyte | 31 | 3 | 5 | 10 | |
| 1930 | NADK/S100A11 ratio | PRORT001571 | 0.70 | Protein ratios | Myeloid | 5 | 2 | 8 | 10 | |
| 1931 | ANGPT1/CPXM1 ratio | PRORT000093 | 0.70 | Protein ratios | Myeloid | 18 | 2 | 7 | 12 | |
| 1932 | CTHRC1 levels | PROLV000556 | 0.69 | Protein levels | Myeloid | 27 | 4 | 11 | 12 | |
| 1933 | LDLRAP1 levels | PROLV001195 | 0.69 | Protein levels | Stromal / connective | 2 | 4 | 6 | 13 | |
| 1934 | Precerebral arterial stenosis and occlusion | VASCU000016 | 0.69 | Vascular | Stromal / connective | 91 | 2 | 11 | 22 | |
| 1935 | ALOX15B levels | PROLV000081 | 0.69 | Protein levels | Lymphocyte | 0 | 6 | 11 | 37 | |
| 1936 | SLC27A4 levels | PROLV001878 | 0.69 | Protein levels | Muscle / cardiac | 1 | 3 | 9 | 20 | |
| 1937 | CDKN1A levels | PROLV000382 | 0.69 | Protein levels | Vascular | 59 | 1 | 5 | 13 | |
| 1938 | EDAR/SNAP23 ratio | PRORT000978 | 0.69 | Protein ratios | Myeloid | 33 | 3 | 15 | 20 | |
| 1939 | CD244/TREML2 ratio | PRORT000410 | 0.68 | Protein ratios | Myeloid | 33 | 5 | 16 | 23 | |
| 1940 | ATRAID levels | PROLV000162 | 0.68 | Protein levels | Granulosa cell | 4 | 0 | 5 | 9 | |
| 1941 | Consultant specialty, trauma and orthopaedics | MISCL000019 | 0.68 | Miscellaneous | Stromal / connective | 2 | 5 | 15 | 14 | |
| 1942 | DAG1/F2R ratio | PRORT000846 | 0.68 | Protein ratios | Myeloid | 18 | 3 | 8 | 18 | |
| 1943 | HSDL2 levels | PROLV000995 | 0.68 | Protein levels | Myeloid | 29 | 1 | 5 | 8 | |
| 1944 | LYPD3 levels | PROLV001252 | 0.68 | Protein levels | Epithelial | 159 | 2 | 5 | 7 | |
| 1945 | SEPHS1 levels | PROLV001812 | 0.68 | Protein levels | Neural / glial | 0 | 2 | 6 | 8 | |
| 1946 | MAP3K5 levels | PROLV001268 | 0.68 | Protein levels | Vascular | 0 | 1 | 4 | 12 | |
| 1947 | FHIT/GLOD4 ratio | PRORT001144 | 0.68 | Protein ratios | Lymphocyte | 0 | 1 | 6 | 29 | |
| 1948 | SERPINH1 levels | PROLV001835 | 0.68 | Protein levels | Vascular | 20 | 1 | 7 | 16 | |
| 1949 | DAB2/FKBP1B ratio | PRORT000836 | 0.68 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 37 | |
| 1950 | CD276 levels | PROLV000326 | 0.67 | Protein levels | Adipose | 14 | 0 | 4 | 4 | |
| 1951 | RBKS levels | PROLV001709 | 0.67 | Protein levels | Hepatocyte | 23 | 1 | 7 | 17 | |
| 1952 | CPA1/CPB1 ratio | PRORT000718 | 0.67 | Protein ratios | Pancreatic epithelium | 32 | 0 | 1 | 3 | |
| 1953 | RBPMS2 levels | PROLV001714 | 0.67 | Protein levels | Vascular | 13 | 5 | 8 | 19 | |
| 1954 | PSMD9/UBAC1 ratio | PRORT001712 | 0.67 | Protein ratios | Muscle / cardiac | 4 | 1 | 4 | 8 | |
| 1955 | P4HB levels | PROLV001481 | 0.67 | Protein levels | Stromal / connective | 66 | 2 | 7 | 26 | |
| 1956 | PDGFB/VEGFC ratio | PRORT001652 | 0.67 | Protein ratios | Neural / glial | 27 | 6 | 12 | 33 | |
| 1957 | IDUA levels | PROLV001013 | 0.66 | Protein levels | Hepatocyte | 160 | 1 | 6 | 10 | |
| 1958 | PCDH7 levels | PROLV001507 | 0.66 | Protein levels | Neural / glial | 6 | 2 | 9 | 16 | |
| 1959 | COCH levels | PROLV000482 | 0.66 | Protein levels | Hematopoietic progenitor | 30 | 3 | 5 | 13 | |
| 1960 | CASP2 levels | PROLV000267 | 0.66 | Protein levels | Lymphocyte | 16 | 3 | 6 | 29 | |
| 1961 | CLEC1B/HBEGF ratio | PRORT000638 | 0.65 | Protein ratios | Myeloid | 60 | 2 | 15 | 15 | |
| 1962 | GALNT5 levels | PROLV000851 | 0.65 | Protein levels | Hematopoietic progenitor | 44 | 4 | 7 | 15 | |
| 1963 | CBLN4/RET ratio | PRORT000326 | 0.65 | Protein ratios | Vascular | 13 | 1 | 8 | 16 | |
| 1964 | EFNA4/TNFRSF10B ratio | PRORT000991 | 0.65 | Protein ratios | Vascular | 0 | 2 | 7 | 23 | |
| 1965 | PPP1R12A levels | PROLV001613 | 0.65 | Protein levels | Platelet | 20 | 2 | 4 | 15 | |
| 1966 | B4GALT1/SPON2 ratio | PRORT000190 | 0.65 | Protein ratios | Hepatocyte | 13 | 1 | 9 | 16 | |
| 1967 | GAPDH levels | PROLV000853 | 0.65 | Protein levels | Muscle / cardiac | 0 | 3 | 9 | 33 | |
| 1968 | GPC1 levels | PROLV000919 | 0.65 | Protein levels | Muscle / cardiac | 104 | 2 | 6 | 8 | |
| 1969 | ATXN10/SLC27A4 ratio | PRORT000163 | 0.65 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 1970 | XPNPEP2 levels | PROLV002199 | 0.64 | Protein levels | Hepatocyte | 67 | 2 | 9 | 14 | |
| 1971 | CCL11 levels | PROLV000278 | 0.64 | Protein levels | Vascular | 47 | 0 | 1 | 5 | |
| 1972 | HSPG2 levels | PROLV000999 | 0.64 | Protein levels | Adipose | 16 | 2 | 5 | 13 | |
| 1973 | LBR/POLR2F ratio | PRORT001439 | 0.64 | Protein ratios | Lymphocyte | 5 | 4 | 8 | 36 | |
| 1974 | ADAMTSL2 levels | PROLV000036 | 0.64 | Protein levels | Hepatocyte | 72 | 3 | 14 | 23 | |
| 1975 | RGCC levels | PROLV001727 | 0.64 | Protein levels | Stromal / connective | 1 | 2 | 4 | 9 | |
| 1976 | USP8 levels | PROLV002146 | 0.64 | Protein levels | Platelet | 2 | 5 | 6 | 11 | |
| 1977 | DAB2 levels | PROLV000591 | 0.64 | Protein levels | Lymphocyte | 6 | 3 | 7 | 19 | |
| 1978 | CELA3A/CPA1 ratio | PRORT000593 | 0.64 | Protein ratios | Granulosa cell | 40 | 2 | 4 | 6 | |
| 1979 | PXN levels | PROLV001688 | 0.64 | Protein levels | Neural / glial | 9 | 4 | 16 | 37 | |
| 1980 | SMAD3 levels | PROLV001896 | 0.64 | Protein levels | Myeloid | 3 | 4 | 8 | 14 | |
| 1981 | Latent factor, red cell | HEMAT000038 | 0.64 | Hematologic | Lymphocyte | 67 | 0 | 1 | 4 | |
| 1982 | CTSE levels | PROLV000563 | 0.64 | Protein levels | Gastrointestinal epithelium | 50 | 0 | 5 | 6 | |
| 1983 | ICA1 levels | PROLV001003 | 0.64 | Protein levels | Myeloid | 31 | 2 | 5 | 18 | |
| 1984 | Retinal disorder | OPHTH000040 | 0.64 | Ophthalmic | Hepatocyte | 88 | 0 | 2 | 3 | |
| 1985 | Venous thromboembolism, VTE | VASCU000066 | 0.63 | Vascular | Hepatocyte | 189 | 1 | 5 | 11 | |
| 1986 | Taurine metabolites | METAB000014 | 0.63 | Metabolites | Vascular | 8 | 0 | 1 | 1 | |
| 1987 | LAG3/VCAM1 ratio | PRORT001418 | 0.63 | Protein ratios | Hepatocyte | 24 | 4 | 13 | 36 | |
| 1988 | CD300C/CLEC14A ratio | PRORT000422 | 0.63 | Protein ratios | Myeloid | 15 | 2 | 9 | 12 | |
| 1989 | CD46/TIMP1 ratio | PRORT000461 | 0.63 | Protein ratios | Lymphocyte | 6 | 2 | 10 | 32 | |
| 1990 | NUDC levels | PROLV001452 | 0.63 | Protein levels | Platelet | 3 | 3 | 3 | 10 | |
| 1991 | CDKN1A/TMSB10 ratio | PRORT000574 | 0.63 | Protein ratios | Hepatocyte | 31 | 2 | 13 | 28 | |
| 1992 | CASP3 levels | PROLV000268 | 0.63 | Protein levels | Platelet | 26 | 3 | 9 | 10 | |
| 1993 | Medication, respiratory | RESPI000007 | 0.62 | Respiratory | Myeloid | 1 | 2 | 6 | 7 | |
| 1994 | Cervical disorder | REPRO000001 | 0.62 | Reproductive | Stromal / connective | 8 | 2 | 9 | 19 | |
| 1995 | Pneumoconiosis | RESPI000015 | 0.62 | Respiratory | Stromal / connective | 0 | 1 | 5 | 10 | |
| 1996 | MB levels | PROLV001281 | 0.62 | Protein levels | Muscle / cardiac | 26 | 3 | 4 | 11 | |
| 1997 | MRPL33 levels | PROLV001339 | 0.62 | Protein levels | Hepatocyte | 21 | 3 | 13 | 11 | |
| 1998 | S100A11 levels | PROLV001766 | 0.62 | Protein levels | Myeloid | 8 | 3 | 11 | 23 | |
| 1999 | F3 levels | PROLV000746 | 0.62 | Protein levels | Vascular | 50 | 0 | 8 | 7 | |
| 2000 | LRRN1 levels | PROLV001236 | 0.62 | Protein levels | Muscle / cardiac | 81 | 3 | 8 | 25 |